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1. INTRODUCTION 
 
1.1. Psoriasis 
 
Psoriasis is a common, lifelong skin disease, affecting approximately 2% of the 
population 
1
 and predominantly presented in the Caucasian population. The disease is less 
common in Asians (about 0.1%) and is rarely seen in Africans 
2
. The prevalence of 
psoriasis is approximately the same in males and females 
3
. Psoriasis has been defined as 
a chronic inflammatory disease with important immune-mediated features that involves a 
multifactorial cellular and molecular network. Psoriasis is generally characterized by 
exacerbation and remission and usually persists through life 
4
. Psoriasis compromises 
innate and adaptive immune system components and has a well-defined network of 
chemokines and messengers. The cause of psoriasis is complex, with evidence that the 
interplay of the multigenic susceptibility and environmental as well as life-style factors 
lead to the development of the symptoms. 
Psoriasis can be provoked by many triggers such as mild trauma (for example 
scratching), sunburn, chemical irritants, infections and factors impairing skin barrier 
function 
5
. Systemic drugs like β-blockers, lithium and non-steroidal anti-inflammatory 
agents can also exacerbate the disease 
6
.  
The clinical manifestation of psoriasis has many faces; the disease is featured by 
variable morphology, distribution and severity. The most common form of the disease is 
chronic plaque psoriasis (psoriasis vulgaris), which manifests as red plaques with silvery-
white scales (Fig. 1. A, B). The well-demarcated regions of inflamed skin (involved skin) 
are clearly distinguished from the normal appearing skin (non-involved skin). Psoriasis 
vulgaris affects approximately 85 to 90% of all patients with the disease 
1,7
. Psoriasis can 
affect any skin site, however typical locations include the extensor surfaces of forearms 
and shins, peri-umbilical, peri-anal, and retro-auricular regions and scalp. Most of the 
affected individuals have a mild form psoriasis defined as a percentage of affected body 
surface area (BSA) even or less than 10%. Up to one third of patients have moderate-to-
severe form of psoriasis affecting more than 10% of the body surface 
8
. 
The plaques are the result of increased keratinocyte proliferation, where up to an 
eight-fold increase in epidermal cell turnover has been demonstrated 
9
 leading to a 
thickening of the epidermis (acanthosis) with elongated rete ridges (Fig. 1. C). The 
differentiation of keratinocytes is extremely altered in psoriasis 
4
. The scales are the result 
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of a hyperproliferative epidermis with premature maturation of keratinocytes and 
incomplete cornification with retention of nuclei in the stratum corneum (parakeratosis). 
The redness of the lesions is due to increased dermal angiogenesis leading to the 
formation of complex underlying vascular system that reaches the skin surface through a 
markedly thickened epithelium. The increased vascularity allows for a greater influx of 
inflammatory cells into the skin, further driving the inflammation. 
Besides the cutaneous symptoms, nail involvement occurs in about 50% of patients with 
psoriasis 
10
 and ranges from pits and yellowish discoloration to a sever nail deformity. 
Approximately 30 % of patients with psoriasis also have joint involvement 
11
. 
 
 
 
Figure 1. Clinical and histological features of psoriasis. (A, B) Clinical presentation of psoriasis showing 
demarcated red plaques with silver scales. (C) Haematoxylin and eosin staining of psoriatic lesional skin 
showing marked epidermal thickening (Clinical and histological photographs are derived from the photo 
archive of the Department of Dermatology and Allergology, University of Szeged) 
 
Psoriasis is associated with a high degree of morbidity; patients are embarrassed 
about the appearance of their skin, and there are also side effects of medications. 
Moreover, patients with psoriasis have reduced levels of employment and income as well 
as a decreased quality of life 
12
. In addition to skin plaques, psoriasis can present with 
various co-morbidities including arthritis, atherosclerosis, inflammatory bowel disease, 
obesity, type 2 diabetes mellitus and depression 
1,13–15
.  
The current existing therapies only relieve symptoms but cannot cure the disease. 
The therapeutic costs are high, moreover some treatments carry substantial side effects. 
9 
 
Therefore the better understanding of the immunopathogenesis of psoriasis is essential for 
the development of improved therapies. 
 
1.1.1. Pathophysiology of psoriasis 
 
The pathophysiology of psoriasis is complex and dynamic. Various combinations of 
selective abnormalities of the immune system and the epithelial cells give rise to the 
psoriatic phenotype 
16
. The recent psoriasis research era proposes that combination of 
environmental, genetic and modifying factors as well as immunologically mediated 
inflammation confers susceptibility to the disease 
17,18
. Genome-wide scans for associated 
genes have identified several immune-related genes 
19,20
, and some susceptibility factors 
related to basic functional abnormalities of keratinocytes 
16
; providing a mechanistic link 
between genetics, immunity, and epithelial cells.  
The epidermal hyperplasia along with abnormal maturation of keratinocytes leads 
to the development of the characteristic thick scaly plaques. Psoriasis shows characteristic 
histopathological changes in almost every cutaneous cell types. The complex interplay of 
cutaneous cells (dendritic cell, T-cell, antigen-presenting cells, neutrophilic granulocytes, 
keratinocytes, vascular endothelial cells, and the cutaneous nervous system) is mediated 
by many cytokines (e.g., interleukin-1, interleukin-6, IFN-γ, TNF-α, etc.) and chemokines 
(e.g., interleukin-8 [CXCL8], CXCL10, CCL20, etc.) that orchestrate the pathologic 
changes in the skin. 
Environmental factors such as physical injury or bacterial infection breaks the 
immunogenic tolerance and starts a set of events that triggers psoriasis in genetically 
predisposed individuals 
7,21
. In the initiation phase, stressed keratinocytes release self-
DNA that forms complex with cathelicidin (LL37), which in turn activates innate immune 
sentinels to produce pro-inflammatory cytokines that mediate the activation of dermal 
dendritic cells (dermal DCs). Activated dermal DCs migrate to the draining lymph nodes 
and induce the differentiation of naïve T-cells such as type 17 helper T cells (Th17) or 
type 17 cytotoxic T cells (Tc17) and type 1 helper T cells (Th1) or type 1 cytotoxic T 
cells (Tc1). The activated T-cells migrate via lymphatic and blood vessels into the dermis, 
attracted by keratinocyte derived chemokines leading to the formation of plaques. 
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Figure 2. Formation of psoriatic lesions from initiation to maintenance of the disease 
(modified figure based on the publication Nestle et al, 2009) 
7
 
 
One of the key processes during disease maintenance is the production of immune 
mediators by T-cells that stimulate keratinocyte proliferation and further cytokine and 
chemokine production of keratinocytes, fibroblasts, NKT cells and DCs. The migration of 
T-cells from the dermis into the epidermis is controlled through the interaction of very 
late antigen 1 (VLA-1) on T-cells and collagen IV at the basement membrane on blood 
vessels and contribute to the disease progression. Feedback loops involving keratinocytes, 
fibroblasts and endothelial cells contribute to tissue reorganization, endothelial cell 
activation and proliferation, and deposition of the extracellular matrix (Fig. 2.). Thus, a 
rich interface between effectors of the innate and adaptive immune system shapes the 
psoriatic inflammatory process. 
11 
 
 
1.1.2. The significance of altered molecular patterns in non-involved skin 
 
Great majority of the researchers have mainly focused on the examination of the 
psoriatic involved skin, however, the healthy looking (non-involved) psoriatic skin also 
carries molecular alterations that could contribute to the pathogenesis of psoriasis. The 
altered skin tissue homeostasis of the normal looking skin of psoriatic patients has key 
importance in the initiation of the disease. The normal looking skin contains abundant 
stores of T lymphocytes 
22
 as well as resident population of DCs  
23
, suggesting that the 
skin might be a potential site for the direct triggering of immune responses 
21
. 
Keratinocytes of the non-involved psoriatic epidermis are inherently oversensitive to 
proliferative signals, and this elevated level of sensitivity plays a crucial role in the 
development of psoriatic lesions 
24,25
. The aim of our workgroup is to identify and 
characterize abnormal molecular patterns in non-lesional psoriatic keratinocytes 
contributing to the initiation of the disease phenotype and factors that make these 
keratinocytes prone to respond with hyperproliferation to cytokines produced by skin 
infiltrating lymphocytes. For that we previously performed a differential display 
experiment to compare the gene expression pattern of non-lesional psoriatic epidermis 
and control healthy epidermis, and then some years later we examined the gene 
expression differences in non-lesional and normal healthy epidermis upon cytokine 
induction, using cDNA microarray method. These two experiments identified several 
molecular patterns in psoriatic non-lesional epidermis that are likely to contribute to 
inherent abnormal reactivity of keratinocytes to various stimuli. Among others, the 
differential display experiment identified a novel non-coding RNA gene, PRINS 
(psoriasis susceptibility-related RNA gene induced by stress) that is significantly 
overexpressed in psoriatic non-lesional epidermis compared either to healthy or psoriatic 
lesional epidermis 
26
. The cDNA microarray revealed that the expression of CARD18 
(caspase recruitment domain family member 18, Iceberg) mRNA is also altered in 
psoriatic non-lesional epidermis upon T lymphokine induction compared to normal 
epidermis 
27
. In the following sections of the dissertation we establish a detailed overview 
of the above mentioned molecules, their molecular characteristics as well as their possible 
contribution to psoriasis. 
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1.2. Non-coding RNAs 
 
Over the last decade, advances in genome-wide analysis of the eukaryotic 
transcriptome have revealed that up to 90% of the human genome are transcribed, 
however, GENCODE-annotated exons of protein-coding genes only cover 2.94% the 
genome, while the remaining are transcribed as noncoding RNAs (ncRNAs) 
28
. 
Noncoding transcripts are further divided into housekeeping ncRNAs and regulatory 
ncRNAs. Housekeeping ncRNAs, which are usually considered constitutive, include 
ribosomal, transfer, small nuclear and small nucleolar RNAs. Regulatory ncRNAs are 
generally divided into two subclasses based on their length. Those less than 200 
nucleotides are usually referred to as short/small ncRNAs, and those longer than 200 
bases are known as long noncoding RNAs (lncRNAs) 
29
. lncRNAs have broad spectrum 
of function: they can serve as signals for cellular information, decoys of RNA and protein 
molecules - thereby inhibiting their functions -, guides for recruitment of transcriptional 
and epigenetic factors, scaffolds for macromolecular assemblies with varied functions 
30
. 
The specific functions of lncRNAs are determined by many factors, such as their tissue-
specific expression, and the physiological status of the cells 
31
. 
 
1.2.1. PRINS, a newly identified long non-coding RNA 
 
PRINS (Psoriasis susceptibility-related RNA gene INnduced by Stress), identified by 
our research group is a 3681-nucleotide-long ncRNA molecule, transcribed by RNA 
polymerase II. BLAST searches (http://blast.ncbi.nlm.nih.gov/Blast.cgi) revealed that the 
PRINS gene is specific for anthropoid primates, its rodent orthologue could not be 
identified. Our studies demonstrated a higher PRINS expression in the uninvolved 
psoriatic epidermis than in either the psoriatic involved or healthy epidermis 
26
. These 
results suggest that the overexpression of PRINS in the uninvolved psoriatic epidermis 
may play a role in psoriasis susceptibility rather than in the precipitation of psoriatic 
lesions, and are in agreement with the previous observations that the keratinocytes of the 
uninvolved epidermis differ from healthy keratinocytes in their responses to external 
stimuli 
24,32,33
. Real time reverse transcription-PCR analysis showed that stress signals 
such as ultraviolet-B irradiation, viral infection (herpes simplex virus), and translational 
inhibition increased the RNA expression level of PRINS. Gene-specific silencing of 
PRINS by RNA interference revealed that down-regulation of PRINS impairs cell 
13 
 
viability after serum starvation but not under normal serum conditions 
26
, suggesting that 
PRINS functions as a noncoding regulatory RNA and plays a protective role in cells 
exposed to stress. Moreover, silencing of PRINS gene resulted in altered HeLa cell 
morphology and gene expression alterations, among others in the case of G1P3, an 
interferon-inducible anti-apoptotic gene 
34
. It has been reported that long mRNA-like 
ncRNAs form complexes with proteins 
35–37
, and act as regulators of various cellular 
functions 
38
. Therefore we have performed an in vitro binding assay which revealed that 
PRINS interacts physically with the molecular chaperone protein nucleophosmin (NPM, 
B23) in HaCaT and normal human epidermal keratinocyte (NHEK) lysates and we were 
first to describe the upregulation of this protein in psoriasis 
39
. 
 
1.2.2. Nucleophosmin, the direct interacting partner of PRINS non-coding RNA 
 
NPM, a multifunctional nucleolar phosphoprotein 
40
, has a potential role as a positive 
regulator in cell proliferation 
41,42
, moreover it is implicated in mRNA processing 
43,44
 and 
also in the acute response of mammalian cells to environmental stress, when it stimulates 
DNA repair and reduces apoptosis 
45
. A number of studies have shown that UV 
irradiation results in a  rapid nucleoplasmic translocation of the otherwise predominantly 
nucleolar protein NPM in  fibroblasts 
45,46
, and cancer cells 
47,48
. Multiple functions of 
NPM conferred by the shuttling of protein between the nucleus and cytoplasm (Figure 3.) 
49
.  
 
 
 
Figure 3. Multiple functions of NPM during shuttling between the nucleus and cytoplasm 
I. Post-transcriptional regulation of specific mRNAs II. Nuclear functions as a histone chaperone and as a 
transcription regulator III. Roles in cell cycle regulation and centrosomal duplication during cell 
proliferation (Modified figure based on the publication of Perbal et al, 2008) 
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It has been demonstrated that NPM forms oligomers involving highly conserved short 
loops, the ionic interactions between the monomeric subunits leading to the formation of 
a thermo-stable, chemically resistant pentamers; it has also been shown that NPM 
pentamers can form decamers in vitro by packing two pentamers on top of each other in a 
sandwich-like structure 
50
. Similar protein oligomer-RNA complexes have been 
documented previously such as the hexameric or heptameric complexes of Sm proteins 
that function as RNA chaperons and fulfill a number of central tasks in various types of 
RNA processing 
51
, and the bacterial Hfq protein that forms hexamers and also functions 
as an RNA chaperone complex 
52
. The heterogeneous nuclear ribonucleoproteins 
(hnRNPs) play an active part in post-transcriptional gene regulation, e.g. RNA splicing 
and regulation of the stability and translation of target mRNAs. Most hnRNPs are 
primarily localized in the nucleoplasm, and can shuttle between the nucleus and the 
cytoplasm 
53
.  
 
1.3. Inflammation, inflammasome signaling 
 
Innate immune responses have the ability to both combat infectious microbes and 
drive pathological inflammation. Inflammation is a non-specific physiological response 
triggered by noxious stimuli and conditions, such as infection, injury, tissue stress or 
malfunction 
54
. Acute inflammation occurs within a few minutes following the injury of 
tissue, initiated by tissue-associated cells. Although acute inflammation is normally self-
limiting and beneficial to host defense and healing, excessive or continuous inflammatory 
responses are associate with impaired regulation of inflammatory signaling and 
subsequently may results in chronic inflammatory or autoimmune disease 
55,56
. 
The innate immune system is composed of germline-encoded pattern recognition 
receptors (PRR) that collectively serve as sensors for monitoring the extracellular and 
intracellular compartments for signs of infection or tissue injury 
57
. PRRs recognize 
damage-associated molecular patterns (DAMP) and pathogen-associated molecular 
patterns (PAMP) 
58
. A key component of cytosolic surveillance is the inflammasome, a 
large multimolecular complex that controls the activation of the proteolytic enzyme 
caspase-1 
59
. Caspase-1 in turn regulates maturation of the pro-inflammatory cytokines 
interleukin-1β (IL-1β), IL-18, or the rapid inflammatory form of cell death, called 
pyroptosis 
60
.  
15 
 
 
Figure 4. Inflammasome components and domain structure 
 
Inflammasomes come in at least two distinct parts: the NLR family members contain 
nucleotide binding and oligomerization domains (NACHTs), leucine-rich-repeats and 
pyrin or card domains (PYDs or CARDs), and the PYHIN family members contain PYD 
and HIN domains. Most NLRs and PYHINs lack CARD domain and require ASC, an 
adaptor molecule that contains PYD and CARD domains. The PYD of ASC interacts with 
the PYD of NLRs or PYHINs, whereas the CARD of ASC recruited to pro-caspase-1 
CARD domain (Figure 4.). The recruitment of pro-caspase-1 into a multiprotein 
inflammasome complex induces auto proteolytic cleavage of pro-caspase-1. Caspase-1 is 
an aspartate-specific cysteine protease that cleaves its substrates, the preform of IL-1β 
and IL-18 
57,61
. IL-1β is produced mainly by monocytes, but also by macrophages, 
dendritic cells and a variety of other cells in the body 
62
. A minute amount of IL-1β in 
vivo can evoke fever, hypotension, release of adrenocorticotrophic hormone and 
production of cytokines which in turn induce various inflammatory and immune 
responses 
63
. Increased IL-1β production has been reported in patients with various 
infections, inflammation, trauma, ischemic diseases, tumors, intravascular coagulation, 
autoimmune disorders, UV radiation, graft-versus-host disease, transplant rejection, and 
in healthy subjects after strenuous exercise 
64
. 
 
1.3.1. AIM2 inflammasome mediated processes in psoriasis 
 
The importance of innate immune dysregulation in psoriasis has long been recognized 
65–67
. The activated state of the innate immune system is represented by the activity of 
NKT cells, dendritic cells, neutrophils and keratinocytes, and an increased expression of 
cytokines 
68
. Pro-inflammatory cytokines, such as IL-1β and IL-18, have been shown to 
play an important role in the pathogenesis of psoriasis, i.e., initiating and mediating the 
infiltration of immune cells and stimulating keratinocytes to proliferate 
17,69,70
 . Elevated 
16 
 
IL-1β and IL-18 expressions have been observed in inflamed skin; moreover, the 
increased IL-1β is produced mostly by keratinocytes 71,72. Certain cytokines, 
inflammasomes and inflammatory caspases, such caspase-1, are also described as 
potential inducers and regulators of skin inflammation in contact hypersensitivity and in 
psoriasis 
68,73
. 
Cytosolic DNA is a potent inducer of the innate immune response and has been 
proposed to be involved in the pathogenesis of psoriasis 
7,74,75
. Keratinocytes express and 
secrete four different deoxyribonucleases (DNases), which remove extracellular DNA by 
degradation. In psoriatic skin, three of these DNases do not exhibit DNase activity and 
one seems to have reduced DNA-affinity. The optimum pH of these DNA binding 
proteins likely changes during keratinization 
76
, resulting in aberrant DNase activity and 
the presence of excess DNA fragments in the cytosol. 
The DNA-sensor-containing absence in melanoma 2 (AIM2) inflammasome is 
triggered by both self-derived (Figure 5.) and pathogen-released (Francisella tularensis, 
Listeria monocytogenes, vaccinia virus) cytosolic double-stranded DNA 
77,78
. Recently, 
abundant cytosolic DNA and increased AIM2 expressions were detected in keratinocytes 
in psoriatic lesions but not in healthy skin 
75
, and suggested to contribute to the abnormal 
IL-1β secretion in psoriasis.  
 
 
 
Figure 5. The signaling of the DNA-sensor-containing AIM2 inflammasome 
 
17 
 
1.3.2. CARD18 (Iceberg), a novel negative caspase recruitment domain 
 
Our recent large-scale gene expression study has revealed that the caspase recruitment 
domain family member 18 (CARD18, Iceberg) transcript is differentially expressed in 
psoriatic non-involved epidermis compared to healthy epidermis 
27
. CARD18, a member 
of CARD-only protein (COP) family, consists of only one CARD domain which exhibits 
sequence similarity (53%) 
79
 to the CARD prodomain of caspase-1. COP family members 
probably arose through gene duplication and are restricted to the higher primates 
80
. 
CARD18 serves as a decoy protein which can modify the activity of inflammasomes by 
inhibiting the generation of active IL-1β and IL-18 through direct interaction with pro-
caspase-1 
81,82
. CARD18 is detected mainly in placenta and in many human cell lines and 
its expression is upregulated by proinflammatory stimuli (LPS and TNF-α) in THP-1 
monocytes 
79
. Moreover, CARD18 inhibited the LPS- or INF-ɣ induced secretion of  IL-
1β in monocytes 82. These data suggest that CARD18 may be a part of a negative 
feedback loop in several professional and non-professional cell types. 
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2. AIMS 
 
2.1. To investigate the physical and functional characteristics of PRINS non-coding RNA 
and its interacting partner, nucleophosmin (NPM) 
 
• To examine the histological and cellular distribution of PRINS non-coding RNA in 
different tissue types 
 
• To study the intracellular localization of NPM under normal conditions and after  
UV-B irradiation in human keratinocytes 
 
• To analyze the effect of PRINS gene silencing on NPM UV-B induced shuttling in 
human keratinocytes 
 
2.2. To investigate the characteristics and functions of the CARD18 molecule in normal 
human keratinocytes and in the skin 
 
• To study the basal expression of CARD18 and its expression changes upon T-cell 
lymphokine treatment in healthy and psoriatic non-involved epidermis 
 
• To analyze the distribution of CARD18 expression under normal conditions and after 
mild injury (tape stripping) in healthy and psoriatic non-involved as well as involved 
epidermis 
 
• To study the cellular expression of CARD18 in spontaneously differentiating normal 
human epidermal keratinocytes 
 
• To analyze the gene expression of molecules involved in inflammasome signaling in 
keratinocytes exposed to cytosolic DNA treatment 
 
• To explore whether the silencing of CARD18 has an effect on keratinocyte innate 
immune functions 
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3. MATERIALS AND METHODS 
 
3.1. Patients 
 
Shave biopsy samples for organotypic skin cultures were taken from the non-involved 
buttock area of five young male psoriasis patients and five age- and gender-matched 
healthy controls. Subsequently, an organotypic skin culture system was established as has 
been described previously 
83
. 
For immunohistochemical staining, patients with moderate-to-severe psoriasis vulgaris 
(n=2) and healthy (n=2) volunteers were enrolled in the study (CARD18 staining). 
Psoriatic patients had not undergone treatment for 4 weeks before sampling. 
In another set of experiments, the skin of psoriatic patients (n=2) and healthy volunteers 
(n=2) were subjected to tape stripping (TS). Punch biopsies were taken from the area 
once before and twice after (24 and 48 hours) the treatment (CARD18 staining). 
Written informed consent was obtained from all donors involved in the study. The study 
was approved by the Human Investigation Review Board of the University of Szeged, 
complying with the ethical standards of research and in accordance with the Helsinki 
Declaration. 
 
3.2. Cell cultures 
 
Normal human epidermal keratinocytes (NHEKs) were separated from skin specimens 
obtained from the Plastic Surgery Unit of our department. The epidermis and the dermis 
were separated by overnight incubation in Dispase (Roche Diagnostics, Manheim, 
Germany), and keratinocytes were obtained after maceration in 0.25% trypsin. Cells were 
grown in 75 cm
2
 cell culture flasks and were maintained in keratinocyte serum-free 
medium (Gibco Keratinocyte SFM Kit; Life Technologies, Copenhagen, Denmark), 
supplemented with 1% antibiotic/antimycotic solution (PAA Laboratories GmBH, 
Pasching, Austria) and 1% L-glutamine (PAA Laboratories) at 37 °C in a humidified 
atmosphere with 5% CO2. The calcium concentration of the medium was <0.1 mM. The 
medium was changed every 2 days. Third passage keratinocytes were used for 
experiments. 
A previously described in vitro keratinocyte differentiating model was used 
84
. For the 
induction of AIM2 inflammasome, cells were subjected to 5 ng/ml tumor necrosis factor 
20 
 
(TNF) α (R&D Systems, Minneapolis, MN, USA) and 5 ng/ml interferon (IFN) ɣ (R&D 
Systems) pretreatment and subsequently transfected with 1 μg/ml polydeoxyadenylic 
acid–polydeoxythymidylic acid double-stranded homopolymer (poly(dA:dT, Sigma 
Aldrich, Saint Louis, MO, USA) transfection using X-tremeGENE 9 transfection reagent 
(Roche). 
Treatment of keratinocytes with psoriasis-related cytokines (here referred to as T-cell 
lymphokines) was carried out as described previously 
27
. Cells were stimulated with the 
mixture of 0.3 ng/ml IL-3 (R&D Systems), 1 ng/ml granulocyte macrophage colony-
stimulating factor (GM-CSF, R&D Systems) and 1 ng/ml IFN-ɣ to the medium. The 
supernatants were collected and cells were harvested at the indicated time points after 
treatments. 
The HPV-Ker cell line was immortalized by the HPV E6 oncogene as described 
previously 
85
. HPV-Ker cells were grown in 75 cm
2
 cell culture flasks and maintained in 
keratinocyte serum-free medium (Gibco® Keratinocyte SFM Kit; Life Technologies, 
Copenhagen, Denmark) supplemented with 1% antibiotic/antimycotic solution (PAA, 
Pasching, Austria) and 1% L-glutamine (PAA, Pasching, Austria) at 37 °C in a 
humidified atmosphere containing 5% CO2. The medium was changed every two days. 
Cells were subjected to UV-B irradiation (312 nm, 40 mJ/cm
2
) in phosphate-buffered 
saline (PBS; 153 mM NaCl, 7.67 mM Na2HPO4, 2.67 mM NaH2PO4) at room 
temperature (RT). Immediately after irradiation, the PBS was aspirated off, and culture 
medium was added to the culture dishes. Cells were harvested at the indicated times after 
UV-B exposure. 
 
3.3. In Situ Hybridization 
 
Custom LNA mRNA detection probes for PRINS with the sequence 5'-3': 
/5DigN/AAGCTTCTGTCCTCATTAGTCTTC/3Dig_N/ and scrambled control sequence  
5'-3': /5DigN/AAGCCTCCGTTCTTATTAGTCTTC/3Dig_N/ were ordered from Exiqon 
(Exiqon A/S, Vedbaek, Denmark). 
For in situ hybridization experiments, patients with moderate-to-severe psoriasis vulgaris 
(n=6) and healthy (n=10) volunteers were enrolled in the study. 
For the detection of PRINS expression in different human tissue types tissue chips were 
used (n=2). Formaldehyde-fixed blocks measuring 4 mm in diameter of normal breast, 
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cerebellum, cerebrum, gallbladder, kidney, large bowel, small bowel, lung, lymph node, 
skin, stomach, testicle and uterus samples were placed into a tissue microarray (TMA) 
block. The fixation of samples was standardized (4% buffered formaldehyde for 24 hours 
at RT, in a volume of 1:10). After paraffin embedding, the TMA was cut into 4-µm-thick 
sections, which were rehydrated with increasing concentrations of alcohol. 
HPV-Ker cells were used for the intracellular detection of PRINS expression. HPV-Ker 
cells were trypsinized and harvested by centrifugation, and resuspended in PBS. 10
5
 cells 
were centrifuged onto a slide by using a cytocentrifuge (Cytopro™, Wescor, Logan, UT, 
USA) and dried overnight at RT. The slides were fixed in 2% paraformaldehyde for 20 
min at RT. 
After 2 × 5-min PBS washes, slides – both with the tissue chips samples and HPV-Ker 
cells - were treated for 15 min and for 5 min, respectively, with 20 μg/mL proteinase K in 
PBS at 37 °C. Digoxigenin-labeled LNA probes suspended in hybridization buffer (50% 
formamide) were denatured at 95 °C for 2 min. Hybridization was performed at 60 °C 
overnight. After hybridization, samples were washed in 5 × SSC (saline–sodium citrate 
buffer) for 15 min, and then 2 × 30 min in 0.2 × SSC at 60 °C. After a 10-min PBS wash, 
samples were equilibrated in 10% goat serum-containing blocking buffer (0.5% blocking 
reagent (Roche, Budapest, Hungary) in PBS containing 0.1% Tween 20) for 1 hour at RT 
and then incubated with anti-DIG alkaline phosphatase (AP) conjugate (Roche 
Diagnostics, Manheim, Germany) diluted 1:500 with blocking solution for 1 h. After 
antibody incubation, samples were washed in PBS containing 0.1% Tween-20 for 2 × 10 
min and in PBS for 2 × 10 min. Coloring reactions were performed overnight with BM 
purple AP substrate (Roche Diagnostics, Manheim, Germany). Slides were mounted with 
Glycergel (Dako Denmark A/S, Glostrup, Denmark). Pictures were taken with the use of 
a Zeiss AxioImager fluorescent light microscope (Carl Zeiss MicroImaging, Thornwood, 
NY, USA) fitted with a PixeLINK CCD camera (PixeLINK, Ottawa, Ontario, Canada). 
 
3.4. Real-time RT-PCR 
 
Total RNA was isolated from cells using TRIzol
®
 Reagent (Invitrogen Corp., Carlsbad, 
CA, USA), following the manufacturer’s instructions. cDNA was synthesized from 1 µg 
total RNA with the iScript cDNA Synthesis Kit (Bio-Rad Laboratories, Hercules, CA, 
USA). Real-time RT-PCR experiments were carried out with the Universal Probe Library 
system (F. Hoffmann-La Roche AG, Basel, Switzerland) or with a Cy5-labeled probe for 
22 
 
PRINS expression studes (CCTTCATCTCACACACCTACGCAG). Primers for the real-
time RT-PCR experiments are listed in Table 1. 
 
  Forward Reverse Probe 
PRINS GAGGCCAGCAGTTTCTACAG AGGGACAACCACATCAAAGC 
Cy5-
labeled 
CARD18 AAGACCCCTCAACTTGCCTCA CTCCCTTGGAAGAAGCTCTG UPL 50 
AIM2 AGTCCTCTGCTAGTTAAGCTCTCTG TCTGACAACTTTGGGATCAGC  UPL 87 
caspase-1 CCTTAATATGCAAGACTCTCAAGGA TAGCTGGGTTGTCCTGCACT  UPL 17 
 
Table 1. Primers used to real-time RT-PCR experiments 
 
PCR assays were performed with the C1000 Touch Thermal Cycler (Bio-Rad 
Laboratories). The expression of each gene was normalized to the 18S ribosomal RNA 
gene. Relative mRNA levels were calculated by the ΔΔCt method. Data from different 
treatments were compared using one-tailed t test. Differences were considered significant 
when P ≤ 0.05. 
 
3.5. Immunohistochemistry 
 
Paraffin-embedded specimens from healthy, involved and non-involved psoriatic skin 
were obtained for CARD18 immunohistochemistry (IHC). Samples were fixed in 4% 
buffered formaldehyde for 24 h. The tissue block was subjected to paraffin embedding 
and 4-μm-thick sections were cut and placed on silanized slides, dewaxed in xylene for 3 
x 5 min and rehydrated in decreasing concentrations of ethanol. Tissue retrieval was 
performed in citrate buffer (10 mM, pH 6.0). For nonspecific antigen blocking, 1% horse 
serum was used for 30 min. Sections were incubated with anti-CARD18 goat polyclonal 
IgG antibody (Santa Cruz Biotechnology, Dallas, TX, USA; 1:300) at 4°C overnight. The 
anti-CARD18 goat polyclonal antibody was not included in the staining procedure when 
sections were stained for the matching negative controls. After three washing steps with 
phosphate-buffered saline (PBS), biotinylated anti-goat IgG (1:200, Vector Laboratories 
Inc., Burlingame, CA, USA) was applied for 30 min at room temperature. After one PBS 
wash, sections were incubated in Extravidin Peroxidase (1:400, Sigma Aldrich) for 30 
min at room temperature. Visualization was performed by adding AEC reagent (0.05% 3-
amino-9-ethylcarbazole dissolved in N,N-dimethylformamide, 0.01% H2O2, and 0.05 M 
acetate buffer). Sections were counterstained with hematoxylin for 10 seconds and 
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subsequently analyzed with a Zeiss Axio Imager fluorescent light microscope (Carl Zeiss 
MicroImaging, Thornwood, NY, USA) fitted with a Carl Zeiss AxioCam MRc camera. 
 
3.6. Immunofluorescence stainings 
 
NHEK cells and HPV-Ker were trypsinized, harvested by centrifugation and resuspended 
in PBS. 10
5
 cells were centrifuged onto a slide using a cytocentrifuge (Cytopro™, 
Wescor, Logan, UT, USA) and dried overnight at RT. The slides were fixed in 2% 
paraformaldehyde for 20 min at room temperature. 
For the detection of NPM expression, nonspecific antigens were blocked for 30 min at RT 
in 1% goat serum containing 0.5% BSA-TBS. Slides were incubated overnight at 4 °C 
with anti-NPM monoclonal antibody (Sigma Aldrich, St. Louis, MO, USA; 1:500) in 
0.5% BSA-TBS. Anti-mouse Alexa Fluor 546 goat anti-mouse IgG secondary antibody 
(Sigma Aldrich, St. Louis, MO, USA; 1:500) was applied for 3 hours at RT.  
For CARD18 detection, nonspecific antigens were blocked for 30 min at room 
temperature in 1% donkey serum containing 0.5% BSA-TBS. Slides were incubated 
overnight at 4
o
C with anti-CARD18 goat polyclonal IgG antibody (Santa Cruz 
Biotechnology; 1:250) in 0.5% BSA-TBS. Anti-goat Alexa Fluor 546 donkey secondary 
antibody (Sigma Aldrich) was applied for 1 hour at room temperature.  
Cell nuclei were counterstained with 4,6-diamidino-2-phenylindole (DAPI, Sigma 
Aldrich, 1:100) and mounted with Fluoromount-G (Southern Biotech, Birmingham, AL, 
USA). Pictures were taken with the aid of a Zeiss Axio Imager fluorescent light 
microscope (Carl Zeiss MicroImaging) fitted with a Carl Zeiss AxioCam MRc 5 camera. 
For the semiquantitative analysis of the intracellular localization of NPM (nucleolar or 
nuclear), at least 25 fields of view were counted per each group by two independent 
examiners. Cells were sorted and counted by observing the localization of NPM 
immunostaining in the nucleolus or in the nucleoplasm. 
 
3.7. Gene specific silencing 
 
Gene-specific silencing of the non-coding RNA PRINS was performed with a vector-
based method described previously 
26
. The most effective PRINS silencing was achieved 
in supplement-free HPV-Ker cell cultures at ~70% confluency, and the transient 
transfection with the in vitro pSilencer™ 2.1-U6 hygro vector (Ambion Inc., Austin, TX, 
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USA) was therefore carried out with these cells. The siRNA sequence targeting PRINS 
gene silencing was as follows: AK696, TTTCTGGAATGATGTCCAA. The scrambled 
sequence (SC1313) was used as control: AACTTTATCTCGGATCTAT. Cells were 
transiently transfected with the plasmids following an X-tremeGENE 9 DNA transfection 
protocol, as described by the manufacturer (Roche Diagnostics, Mannheim, Germany). 
Transfection efficiency was on average 85%, as checked with a GFP reporter construct 
(Lonza, Basel, Switzerland). The effectiveness of the silencing was measured by real time 
RT-PCR (Supp. Fig.1). 
Gene-specific silencing of CARD18 was performed with an siRNA transfection method. 
NHEK cells were transiently transfected at approximately 70% confluency using the X-
tremeGENE siRNA Transfection Reagent (Roche), according to the manufacturer's 
instructions. For gene-specific silencing of CARD18, an siRNA duplex was applied: 
ICEBERG siRNA (h), sc-105550, and control siRNA-A, sc-37007 (Santa Cruz 
Biotechnoloby). The most effective CARD18 silencing was achieved in serum-free 
culture medium without additive and supplements. The effectiveness of the silencing was 
measured by real-time RT-PCR (Supp. Fig.2). 
 
3.8. ELISA 
 
Cell supernatants were collected and the debris was removed by centrifugation (5000 
rpm, 4 min, 4°C). The amount of IL-1β was determined by ELISA (IL-1β ELISA Duo 
Set, R&D Systems), according to the manufacturer's instructions. 
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4. RESULTS 
 
4.1. PRINS ncRNA shows variable histological and cellular expression level 
 
The previous real-time RT-PCR studies of our workgroup have demonstrated 
differences in PRINS expression in various human tissue samples 
26
. For a detailed 
analysis of cellular and histological distribution of PRINS ncRNA we have applied ISH. 
To investigate the PRINS expression pattern in different tissue types, we applied paraffin-
embedded tissue chips containing thirteen sections from different healthy human organs 
on one slide. The samples were exposed to the same conditions during ISH which led to 
good comparability of different tissue types. The intracellular distribution of PRINS was 
also examined in cultured NHEKs. 
The ISH experiments demonstrated variable levels of expression in different human 
tissue samples: high levels of PRINS expression were detected in the gut, lung, lymph 
node, uterus, testicle and skin (Figure 6A–H), whereas no staining was observed in the 
cerebrum and cerebellum (data not shown). The breast, kidney, stomach, and gallbladder 
tissue specimens displayed only moderate PRINS expressions (data not shown). These 
findings are in agreement with our previous results revealing variable PRINS gene 
expression levels in different healthy human organs. 
We paid a special attention to the skin samples and their careful analysis revealed 
that the dermal and epidermal expression of PRINS significantly differed. Within the 
epidermis, a strong staining intensity was similar in the various layers, however, stratum 
granulosum and stratum lucidum exhibited somewhat more intensive PRINS ISH staining 
(Figure 6G,H). This staining is regarded specific, since the scrambled control probe did 
not result in the same staining intensity in these layers. There was only a moderate 
positivity in the dermis. 
In vitro cultured keratinocytes (Figure 6I) exhibited strong nucleolar (indicated by 
small arrows) and perinuclear PRINS positivity and moderate homogeneous cytoplasmic 
staining. The cellular expression profile of PRINS is in agreement with the staining 
pattern of keratinocytes seen in the epidermal layers of skin samples. 
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Figure 6. Detection of PRINS expression in various human tissue samples by ISH. The sections were 
incubated with an LNA RNA detection probe for PRINS and for the control staining (see insets at the same 
magnification) we used a scrambled control sequence. Relatively strong PRINS positivity was seen in the 
(A) lungs; (B) the large bowel; (C) the small bowel; (D) the lymph nodes; (E) the uterus; (F) the testicles; 
(G,H) the skin; and (I) cultured keratinocytes. 
 
4.2. PRINS expression differs in healthy and psoriatic skin 
 
With a quantitative RT-PCR approach our workgroup earlier showed that PRINS 
was expressed more strongly in the psoriatic uninvolved epidermis than in either the 
normal or the involved epidermis
26
. To visualize their differences, ISH experiments were 
performed to compare the expressions of PRINS in normal healthy (n = 10), psoriatic 
uninvolved (n = 6) and psoriatic involved (n = 6) skin samples.  
The ISH results partially confirmed the real time RT-PCR findings, indicating a 
moderately elevated level of PRINS expression in the uninvolved (Figure 7B) and 
involved (Figure 7C) epidermis relative to the healthy epidermis (Figure 7A). However, 
the differences in expression between the involved and uninvolved epidermis were not as 
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pronounced as with the real time RT-PCR approach. The explanation for this may lie in 
the differential sensitivity of the two methods. 
 
 
 
Figure 7. Detection of PRINS expression in psoriasis. ISH for PRINS expression was performed on 
healthy normal (n = 10), psoriatic uninvolved (n = 6) and psoriatic involved (n = 6) skin specimens. 
Sections were incubated with the PRINS-specific LNA probe or with the control scrambled (see insets at 
the same magnification) LNA probe. Representative staining for each tissue types: (A) normal healthy skin; 
(B) psoriatic uninvolved skin; and (C) psoriatic involved skin. Bar = 100 µm. 
 
4.3. Intracellular localization of NPM protein in keratinocytes upon UV exposure 
 
By performing three independent binding experiments, our colleague Krisztina 
Szegedi identified nucleophosmin as a putative PRINS-binding protein 
39
. NPM is a 
ubiquitously expressed nuclear phosphoprotein which shuttles continuously between the 
nucleus and the cytoplasm
86
. Within the nucleus, NPM is predominantly localized in the 
nucleoli, with its highest levels in the granular component that contains the more mature 
pre-ribosomal particles
40
, but a significant fraction of NPM can also be detected in the 
nucleoplasm. NPM is a multifunctional protein with multiple locations in the cell. During 
the cell cycle, NMP is dynamically localized
87
 and it is also redistributed from the 
nucleolus in response to cytotoxic drugs and genotoxic stress. In fibroblasts and cancer 
cells, UV irradiation results in a rapid nucleoplasmic translocation of the nucleolar 
NPM
46,88
. To investigate whether we could observe a similar intracellular localization of 
NPM in keratinocytes after UV-irradiation, we applied an immunocytochemistry method. 
In these experiments, we used HPV-Ker cells, a keratinocyte cell line newly established 
by our workgroup 
85
. The UV responses of NHEKs and HPV-Ker cells were compared. 
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Figure 8. UV-B radiation induces the intracellular trafficking of nucleoplasmic NPM in 
keratinocytes. Unirradiated and UV-B-irradiated (312 nm, 40 mJ/cm2) cells were followed for the 
indicated periods of time, fixed and immunostained for NPM. DNA was stained with DAPI. (A) HPV-Ker 
cells (B) NHEK cells. Magnification: 20X 
 
UV-B exposure caused a relocalization of NPM from the nucleolus to the 
nucleoplasm in HPV-Ker cells (Figure 8A). The UV-B-induced subcellular shuttling 
could be detected quite early after UV-B irradiation: slight translocational changes were 
observed 3 h after treatment. The immunofluorescence intensity of NPM staining in the 
nucleoplasm was the most abundant at 12 and 24 h. Forty-eight hours following UV-B 
treatment, the protein had mostly returned to the nucleolus. The time course studies 
showed that the stimulation of NPM shuttling by UV-B irradiation was a rapid and 
transient process. The intracellular localization pattern of NPM after UV-B exposure was 
similar in both the cultured NHEKs (Figure 8B) and the HPV-Ker cells, which suggests 
that HPV-Ker cells could be appropriate models for further studies on intracellular NPM 
trafficking. 
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4.4. PRINS modifies the UV-B-induced intracellular shuttling of NPM 
 
To determine whether PRINS had any effect on the intracellular trafficking of 
NPM, we silenced the expression of PRINS in growth factor-deprived HPV-Ker cells 
with a vector-based method
26
 and studied the NPM shuttling under normal conditions and 
after UV-B exposure. NPM shuttling was compared in HPV-Ker cells transfected with a 
specific PRINS-silencing construct (AK696) and in HPV-Ker cells transfected with a 
control construct (SC1313). 
 
 
 
Figure 9. Silencing of PRINS expression modifies the UV-B-induced trafficking of NPM. HPV-Ker 
cells were transfected with a PRINS gene-specific silencing vector (AK696). Control cells were transfected 
with a vector containing a scrambled sequence (SC1313). One day after the transfection, the unirradiated 
(A) and the UV-B-irradiated (B) HPV-Ker cells were followed for the indicated periods of time, fixed and 
immunostained for NPM. DNA was stained with DAPI. Magnification: 20X 
 
In untreated samples, NPM was localized mostly within the nucleolus in both the 
SC1313- and the AK696-transfected cells (Figure 9A). The relocalization of NPM from 
the nucleolus to the nucleoplasm in the control SC1313-transfected cells at the indicated 
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times after UV-B exposure was similar to our preliminary observations in HPV-Ker cells. 
As compared with the control cells, cells transfected with the PRINS silencing vector 
(AK696) (Figure 9B) showed a moderate retention of NPM in the nucleolus following 
UV-B treatment. 
To validate the immunocytochemical observations, a semiquantitative analysis was 
performed (Figure 10). The nuclear transition of NPM was inhibited in AK696-
transfected cells after UV-B irradiation. Interestingly, we observed that the transfection 
itself slightly modified the shuttling of NPM even in the UV-B negative group. 
 
 
 
Figure 10. A semiquantitative analysis of the cells was performed following the immunostaining. 
In every group, 25 fields of view were counted. Mean values are plotted on the chart. 
 
4.5. CARD18 gene expression differs in healthy and psoriatic non-involved 
epidermis upon T-cell lymphokine treatment 
 
We and others have presented evidence that psoriatic non-involved epidermal 
keratinocytes carry molecular and cellular alterations that contribute to the occurrence of 
psoriatic symptoms. Along with this work we have recently reported the results of a 
cDNA microarray experiments in which we detected that 61 annotated genes were 
differentially expressed in psoriatic non-involved and healthy epidermis upon T-cell 
lymphokine treatment 
27
. In this experiment, organotypic skin cultures were treated with a 
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cytokine mixture (GM-CSF, IL-3, IFN-ɣ) that has been shown to mimic the effect of 
psoriatic T-cell lymphokines 
89
. CARD18 was identified as differentially expressed gene 
in this experiment. CARD18 encodes a protein that belongs to the COP family, inhibiting 
inflammasome activation directly by interacting with pro-caspase-1 and serves as a 
negative regulator of IL-1β maturation 60. 
To validate the cDNA microarray results, real-time RT-PCR analysis was carried 
out to measure the abundance of CARD18 mRNA (Figure 10). For that we used the 
original RNA samples derived from organotypic skin cultures (healthy epidermis, n=5 
and psoriatic non-involved epidermis, n=5). 
 
 
 
Figure 11. CARD18 gene expression in healthy and non-involved psoriatic epidermis. Total RNA was 
isolated from the epidermal compartment of organotypic skin cultures (n=5). CARD18 gene expression 
changes in response to T-cell lymphokine (GM-CSF, IL-3, IFN-ɣ) treatment in healthy epidermis and in 
non-involved psoriatic epidermis. Horizontal lines represent mean values. 
 
Our results confirmed the cDNA microarray results: we observed a 2-fold elevation 
of CARD18 mRNA level in psoriatic non-involved epidermis compared to healthy 
epidermis. Although the basal expression levels were relatively high in the psoriatic non-
involved epidermis, it was not further induced in response to T-cell lymphokines. This 
was in contrast to the findings for healthy skin, where lower basal expression levels were 
induced with a 1.65-fold elevation in response to the same treatment (Figure 11). 
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4.6. CARD18 is abundantly expressed in differentiating keratinocytes 
 
To examine the characteristics of CARD18 in NHEKs, we examined mRNA and 
protein changes in spontaneously differentiating NHEKs. In spontaneously differentiating 
third-passage NHEKs, the differentiation process was detected by increaseing keratin 10 
as a differentiation marker, and by decreasing alpha5 integrin expression as a 
proliferation-related marker (data not shown). The 0-day samples were taken from 
subconfluent cultures. To determine the mRNA expression of CARD18, real-time RT-
PCR was carried out using gene-specific primers. The in vitro gene-expression study 
revealed low-level CARD18 mRNA expression in the proliferative state of cells, and this 
expression continuously increased during differentiation up to 43.2-fold elevation in the 
10-day samples (Fig. 12A). 
 
 
 
Figure 12. Expression of CARD18 mRNA and protein during keratinocyte proliferation and 
differentiation. Cultured NHEKs (n=3) were grown till subconfluency before samples were taken (0 day). 
(A) Changes in CARD18 mRNA expression were analyzed by real-time RT-PCR at the indicated time 
points. Relative expression is shown compared to the 0-day sample. (B) CARD18 intracellular protein 
localization was detected in NHEKs (n=3, one representative picture is shown) at the indicated time points. 
Samples were fixed and immunostained for CARD18 (red). DAPI was used for nuclear counterstaining. 
Magnification: 20X 
 
To examine the expression of CARD18 protein, immunofluorescence staining was 
applied to keratinocytes, revealing that moderate positive CARD18 protein expression in 
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samples taken on days 0–4 gradually increased in the 6–10-day samples (Fig. 12B). Thus, 
CARD18 protein expression followed a similar pattern observed for the mRNA 
expression during the 10-day course. The immunocytochemistry staining allowed the 
intracellular distribution to be determined and revealed that CARD18 was located in the 
cytoplasm of NHEKs, as it was observed in the epidermal keratinocytes of the ex vivo 
samples (see later; Fig.13-14). 
 
4.7. CARD18 expression differs in healthy and diseased skin 
 
Using an organotypic skin model, we previously determined that CARD18 mRNA 
abundance was higher in psoriatic non-involved epidermis compared to healthy 
epidermis. To compare CARD18 protein levels in healthy and diseased skin, 
immunohistochemical (IHC) staining was performed on paraffin-embedded samples from 
healthy (Fig. 13A), psoriatic non-involved (Fig. 13B) and psoriatic involved skin samples 
(Fig. 13C) in an independent experiment. 
 
 
 
Figure 13. Immunohistochemical staining of CARD18 in healthy and psoriatic skin. CARD18 protein 
levels were analyzed in healthy volunteers (n=10) and patient with psoriasis (n=6). One representative 
picture is shown of healthy (A), psoriatic non-involved (B), and psoriatic involved (C) skin. Negative 
controls were performed for healthy (D), psoriatic non-involved (E) and psoriatic involved skin (F). Bar = 
100 μm 
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In all examined sections, CARD18 appeared exclusively in the epidermis, 
specifically in the cytoplasm of epidermal keratinocytes. IHC revealed differential 
CARD18 expression in different skin samples: elevated levels were observed in the 
psoriatic non-involved and psoriatic-involved epidermis compared to healthy epidermis 
(Fig 13B and 13C vs 13A). These results confirmed our real-time RT-PCR findings. No 
differences were detected in the different keratinocyte layers of the epidermis; however, 
the level of CARD18 staining was somewhat higher in the suprabasal layers of psoriatic 
non-involved and involved epidermis. Figure 13D-F provide the data from negative 
controls for figures 13A-C. 
 
4.8. CARD18 expression is differentially induced in healthy, psoriatic non-involved 
and psoriatic involved epidermis after tape stripping (TS) 
 
Mechanical stress causing disruption of the skin barrier leads to molecular 
responses, including a rapid increase in DNA synthesis and early over-expression of pro-
inflammatory cytokines 
90,91
. It has long been known that baseline proliferative activity of 
keratinocytes of non-involved skin of psoriatic patients does not differ from keratinocytes 
in skin of healthy individuals; however, the proliferative response to TS or other trauma is 
significantly higher in psoriatic non-involved skin compared to healthy skin 
92–94
. Our aim 
was to study weather CARD18 has a differential expression in these skin types upon TS. 
Therefore CARD18 protein expression was observed in mechanically stimulated skin 
from healthy, involved and non-involved skin of psoriatic donors. Punch biopsies were 
taken before the procedure and two times after TS (24 and 48 hours). Compared to 
untreated sections (Fig. 14A, D, G), CARD18 protein expression level was induced 24 
hours after TS in healthy (Fig. 14B), psoriatic non-involved (Fig. 14E) and psoriatic 
involved (Fig. 14H) samples, as well. However, the elevation of CARD18 expression in 
treated and untreated psoriatic non-involved samples was not as pronounced as in healthy 
or psoriatic involved skin. Forty-eight hours after the treatment, CARD18 expression 
remained elevated only in the psoriatic non-involved samples (Fig. 14F). Results from 
negative-control staining of the TS experiment proved the specificity of stainings (Supp. 
Fig. 3). 
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Figure 14. CARD18 expression upon acute barrier disruption. Tape stripping (TS) method was carried 
out on the skin of healthy (n=2, one representative picture is shown) and psoriatic volunteers (n=3, one 
representative picture is shown). Punch biopsies were taken at the indicated time points. Skin samples were 
subjected to immunohistochemical staining of CARD18: healthy untreated (A), healthy TS at 24 h (B), 
healthy TS at 48 h (C), psoriatic non-involved untreated (D), psoriatic non-involved TS at 24 h (E), 
psoriatic non-involved TS at 48 h (F), psoriatic involved untreated (G), psoriatic involved TS at 24 h (H), 
psoriatic involved TS at 48 h (I). Bar = 100 μm 
 
4.9. T-cell lymphokine treatment does not induce altered inflammasome signaling in 
keratinocytes 
 
To elucidate the cellular processes in which CARD18 participates and to gain 
further insight into its role in the pathomechanism of psoriasis, we investigated CARD18 
expression in response to a T-cell lymphokine mixture containing GM-CSF, IL-3 and 
IFN-ɣ, a cytokine mix that has already been characterized in psoriasis 89. Keratinocytes, 
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important immune-competent cells, are able to sense danger signals and mediate immune 
responses through the activation of pro-inflammatory signaling pathways 
17
, resulting in 
the expression of inflammasome components and secretion of pro-inflammatory 
cytokines 
95
. Twelve hours after cultured NHEKs were incubated with the T-cell 
lymphokine mixture, a significant increase in CARD18 expression was observed 
compared to the untreated cells (Figure 15), and these results were in accordance to those 
obtained with healthy epidermis in organotypic skin culture 
27
. 
 
 
 
Figure 15. CARD18 mRNA expression upon T-cell lymphokine treatment in NHEKs. NHEK cultures 
(n=3) were incubated with GM-CSF, IL-3, and IFN-ɣ. Samples were taken at the indicated time points. 
CARD18 mRNA expression was analyzed by real-time RT-PCR at the indicated times. Expression is 
relative to the 0 hour sample. * P>0.05 
 
The same T-lymphokine treatment was previously shown to up-regulate IL-1β gene 
expression 
27
. It has been reported that the inflammatory IL-1β cytokine has an important 
role in skin inflammation and that posttranscriptional activation of IL-1β is mediated by 
inflammasome activation and caspase-1 proteolytic cleavage. In addition, the relationship 
between the AIM2 inflammasome and cutaneous inflammation in psoriatic skin has been 
established 
75
. 
Therefore we investigated AIM2 and caspase-1 gene expression together with IL-1β 
secretion in NHEKs during T-cell lymphokine treatment. The treatment had no effect 
either on AIM2 (Supp.Fig. 4A) and caspase-1 (Supp.Fig. 4B) mRNA expression and or 
on IL-1β secretion (data not shown).  
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4.10. Modifying effect of CARD18 silencing on molecules involved in cytosolic DNA-
triggered responses of NHEKs 
 
Since the T-cell lymphokine treatment had no effect on inflammasome signaling 
molecules, we turned our attention to other psoriasis-associated aspects of cellular 
responses. Cytosolic DNA has been recently identified as a trigger for AIM2 
inflammasome activation. It has been also demonstrated that it is abundant in psoriatic-
involved epidermis 
75,96
. To mimic the effect of cytosolic DNA, a synthetic dsDNA 
analogue poly(dA:dT) was transfected into cultured keratinocytes. 
A significant increase in IL-1β release - up to 50 pg/ml (Fig. 16A) - as well as 3–5 
fold increase in caspase-1 mRNA expression (Fig. 16C) and a 200-fold increase in AIM2 
mRNA expression (Fig. 16D) were observed, although changes in CARD18 mRNA were 
not detected (Fig. 16B). 
 
 
 
Figure 16. The effect of synthetic DNA analogue (poly(dA:dT)) transfection in NHEKs. NHEK 
cultures (n=3) were transfected with poly(dA:dT) before taking samples at the indicated times. IL-1β 
secretion (A) was measured by ELISA. CARD18 (B), caspase-1 (C) and AIM2 (D) mRNA expressions 
were analyzed by real-time RT-PCR. Expression is relative to the 0 hour sample. * P>0.05 
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To provoke enhanced inflammatory reactions, a combined IFN-γ and TNF-α pre-
treatment was performed before poly(dA:dT) transfection. IFN-γ is known to induce 
AIM2 gene expression 
97
, whereas TNF-α mediates pro-IL-1β transcription 98, and both 
cytokines are consistently elevated in psoriatic skin. The co-treatment resulted in 
increased IL-1β secretion - up to 100 pg/ml (Fig. 17A) - and increased the expression of 
caspase-1 and AIM2 mRNAs by 13-fold (Fig. 17C) and 250-fold (Fig. 17D), respectively. 
CARD18 mRNA level was also increased by six fold (Fig. 17B). 
 
 
 
Figure 17. The response of cytokine-primed keratinocytes to synthetic DNA analogue (poly(dA:dT)) 
transfection. NHEK cultures (n=3) were incubated with IFN-ɣ and TNF-α for 24 hours, followed by 
poly(dA:dT) transfection. Samples were taken at the indicated times. IL-1β secretion (A) was measured by 
ELISA method. CARD18 (B), caspase-1 (C) and AIM2 (D) mRNA expression was determined by real-time 
RT-PCR. Relative expressions are shown compared to the 0 hour sample. * P>0.05 
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These results encouraged us to further characterize the function of CARD18 in 
keratinocytes in which inflammatory processes had been induced. CARD18 expression 
was silenced by siRNA 24 hours before IFN-γ and TNF-α treatment and subsequent 
poly(dA:dT) transfection. The applied siRNA treatment effectively down-regulated 
CARD18 expression to 50% of the levels observed in the control cells transfected with 
the scrambled DNA sequence (Fig. 18B). 
 
 
 
Figure 18. The effect of CARD18 gene-specific silencing in cytokine-primed poly(dA:dT) transfected 
NHEKs. CARD18 expression was silenced in NHEK cultures (n=3). CARD18 siRNA, scrambled control 
and mock-transfected cells were subsequently treated with a mixture of IFN-ɣ and TNF-α (12 hours) and 
transfected with poly(dA:dT). Samples were taken at the indicated times. IL-1β secretion (A) was measured 
by ELISA. CARD18 (B), caspase-1 (C) and AIM2 (D) mRNA expression was analyzed by real-time RT-
PCR. Expression is relative to the 0 hour sample, except for AIM2, where arbitrary units were used.             
* P>0.05 
 
CARD18 silencing resulted in a significant decrease in AIM2 gene expression 12 
and 24 hours after treatment (Fig. 18C) and significantly reduced caspase-1 mRNA 
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expression (Fig. 18D) 24 hours after the treatment. For further confirmation, we 
determined whether the silencing of CARD18 had any effect on IL-1β secretion: our 
results indicated that downregulation of CARD18 expression resulted in an elevated IL-
1β production in keratinocytes (Fig. 18A). These results indicate that CARD18 might 
indeed contribute to the fine-tuning of inflammatory processes in keratinocytes and 
suggest that — similar to the role in professional immune cells 81 — functions as a 
negative regulator of inflammasome activation in keratinocytes. 
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5. DISCUSSION 
 
Psoriasis is an inflammatory skin disease affecting approximately 2% of the 
population. Symptoms of the disease may vary from mild to life-threatening severe forms, 
but any forms of the disease may have tremendous effects on life quality. Psoriasis is a 
multifactorial disorder: genetic susceptibility, environmental and life-style factors all 
contribute to the development of the disease which is characterized by inflammation and 
the thickening of the epidermis due to keratinocyte hyperproliferation. The two main cell 
types playing key roles in disease pathogenesis are keratinocytes and the so-called 
professional immune cells. 
Accumulating evidence suggest that altered skin tissue homeostasis, especially 
keratinocyte-specific alterations of the normal looking skin of psoriatic patients are key in 
the initiation of the disease phenotype. The „immune era” of psoriasis research 
unquestionably brought a breakthrough in the new, targeted therapies of the disease, but 
to identify novel targets for intervention and possibly for prevention, we must understand 
the role of aberrant keratinocyte functions in the course of the disease. The newly 
emerging era of drug development in psoriasis targets abnormal intracellular processes 
and favors the application of small molecules. 
In the last decade we have performed several experiments to discover abnormal 
molecular patterns of psoriatic non-lesional keratinocytes. These large-scale gene 
expression studies identified the two molecules that are in the focus of this PhD thesis. 
According to our results, both PRINS non-coding RNA and CARD18 molecule showed 
altered expression profile in psoriatic non-involved epidermis compared to healthy 
epidermis, so we aimed to investigate the function of these two molecules in 
keratinocytes and in psoriasis. 
 
Previously, our research group investigated the tissue specificity of PRINS expression 
by real-time RT PCR. Those results revealed that the PRINS non-coding RNA is 
expressed in various human tissues types and the level of expression showed marked  
differences.  
In the present study we have analyzed the histological distribution of PRINS on 
thirteen different tissue types using in situ hybridization method. The ISH experiments 
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demonstrated variable staining pattern and intensity in human tissue samples: high levels 
of PRINS were detected in the gut, lungs, lymph nodes, uterus, testicles and skin, 
however no staining was observed in the cerebrum and cerebellum. These results are in 
agreement with the previous real-time RT-PCR data. In human skin we saw a strong 
PRINS staining intensity in the epidermis. In contrast to that, there was a very low - 
sometimes undetectable – PRINS expression in the dermis. Taken together, the in situ 
hybridization experiments demonstrated that PRINS is expressed in various tissue types 
but the level of expression shows great variety; moreover, the staining specificity 
suggests that PRINS may have an important function in the human epidermis. 
After the comparison of the different tissue types, we have studied the differential 
distribution of PRINS in healthy and diseased skin samples. The ISH results indicated a 
slightly elevated PRINS expression in psoriatic involved and non-involved epidermis 
compared to the healthy epidermis. The different distribution and expression of PRINS in 
the epidermal keratinocytes could be correlated with the abnormal keratinocyte functions 
seen in psoriasis and with the skin-relevant stress factors inducing the epidermal stress 
response. 
We have previously demonstrated that the PRINS ncRNA interacts physically with the 
chaperone molecule nucleophosmin (NPM) 
39
. The crucial regulatory roles of NPM in 
cell proliferation and cellular stress response have already been described 
99,100
.  It has 
been also established that the nucleolar–nucleoplasmic shuttling of the multifunctional 
phosphoprotein NPM is affected by ultraviolet (UV) light in fibroblasts and cancer cells. 
Since there was no data about NPM shuttling characteristics in keratinocytes, we have 
investigated the NPM localization in HPV-Ker and NHEK cells upon UV-B exposure. 
Our study of the intracellular trafficking of NPM revealed similar NPM localization 
pattern in HPV-Ker and NHEK cells that was seen in fibroblasts and cancer cells; 
particularly, UV-irradiation caused a relocalization of NPM from the nucleolus to the 
nucleoplasm.  
During our functional experiments we have silenced the gene expression of PRINS. 
The gene-specific silencing of the PRINS expression in UV-B-irradiated keratinocytes 
resulted in the retention of NPM in the nucleolus, suggesting that PRINS is physically 
and functionally linked to NPM. 
The data we have reported here suggest that PRINS might be part of a regulatory 
complex formed with NPM. The resulting complex may play a role in the regulation of 
proliferation and differentiation and in the stress response of cells. We hypothesize that 
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the abnormal functioning of this complex contributes to the pathogenesis of both 
malignant and benign hyperproliferative diseases, such as psoriasis. 
 
CARD18 has been identified as a negative regulator of inflammasome activation 
through direct interaction with the CARD domain of pro-caspase-1 and abrogation of IL-
1β and Il-18 production in macrophages 79. We have identified CARD18 as a highly 
expressed transcript in psoriatic non-involved epidermis and demonstrated its abnormal 
regulation in psoriatic non-involved epidermis 
27
. 
IL-1β is an important mediator in the induction and maintenance of psoriasis 101,102 and 
represents a potential therapeutic target; therefore several studies have targeted possible 
inhibitors of IL-1β 103–105. IL-1β and IL-18 are generated by a number of different 
inflammasomes in response to various environmental influences and this process is likely 
further modulated by additional genetic factors 
106
. The importance of these multi-protein 
platforms has been reported in several inflammatory diseases, including psoriasis 
107,108
. 
Specific inflammasome inhibitors rectify the balance between beneficial and deleterious 
IL-1β and IL-18 production. To understand the pathologic functions of CARD18 in skin 
inflammation, we studied CARD18 under normal and inflammatory conditions both in 
vitro and in vivo. 
In organotypic skin cultures, basal CARD18 mRNA expression level was higher in 
psoriatic non-involved epidermis than in healthy epidermis. In addition, samples of 
different origin exhibited different responses to lymphokine induction. Healthy epidermis 
exhibited lower CARD18 mRNA basal expression, which was induced by the cytokine 
treatment. In contrast, the higher basal expression of CARD18 mRNA in psoriatic non-
involved samples was not further increased following T-cell lymphokine treatment.  
In human skin, CARD18 protein and mRNA exhibited similar accumulation patterns: 
histological staining showed higher CARD18 expression in non-involved and involved 
epidermis than in healthy epidermis. Mild injury (i.e., TS) induced CARD18 protein 
expression in all examined skin samples; however, the level of induction was different: 
the modest elevation was detected in psoriatic non-involved epidermis compared to 
healthy and psoriatic involved epidermis. The higher basal level and the lack of response 
of CARD18 gene and protein expression in psoriatic non-involved epidermis might 
indicate a “ceiling effect” or impaired regulation of inflammatory signaling, similar to the 
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phenomenon that has been described for IL-1β production in keratinocytes and in salivary 
glands 
27,109
. 
Although keratinocytes are able to express inflammasome components and secrete IL-
1β, we observed very low — sometimes undetectable — levels of AIM2, caspase-1 and 
CARD18 mRNA and IL-1β secretion in untreated keratinocytes. Compared to the 
untreated cells, however, treatment with a combination of inflammation-related stress 
factors significantly increased both the expression of inflammasome components and IL-
1β secretion. The applied triggering factors, such as IFN-γ and TNF-α priming followed 
by synthetic dsDNA analogue poly(dA:dT) transfection are also known to contribute to 
the pathogenesis of psoriasis 
7,75
. 
Furthermore, to gain some information about the function of CARD18 in keratinocytes 
under inflammatory conditions, we silenced CARD18 expression. CARD18 silencing 
resulted in a modest but significant elevation of IL-1β secretion in poly(dA:dT)-treated 
cells, suggesting that, similar to professional immune cells, CARD18 indeed has a 
negative regulatory role in keratinocyte innate immune functions. Interestingly, reduced 
inflammasome activation was detected as decreased AIM2 and caspase-1 gene expression 
in the CARD18-silenced cells. We hypothesize that IL-1β secretion is a highly regulated 
process both in professional and in non-professional immune cells, such as keratinocytes. 
Thus, the silencing of CARD18 might up- and down-regulate multiple process 
simultaneously, resulting in only a mild change in IL-1β secretion. The reduced 
inflammasome activation data suggest the present of a negative feedback loop: elevated 
active caspase-1 down-regulates caspase-1 and AIM2 gene expression through a yet 
unknown control mechanism. Juruj et al have recently published results supporting this 
hypothesis: the authors demonstrated that caspase-1 negatively regulated the formation or 
stability of the AIM2 inflammasome complex, and that this regulation was specific to the 
AIM2 inflammasome pathway in macrophages 
110
. 
Nair and coworkers demonstrated that caspase-1, AIM2 and IL-1β mRNAs are present 
at low levels in healthy and non-involved skin, and that the expression of these molecules 
increases significantly in psoriatic involved skin 
111
. Moreover, caspase-1 protein 
expression is increased in involved psoriatic skin compared to non-involved psoriatic 
skin, whereas procaspase-1 expression is unchanged. Under normal conditions, caspase-1 
activity has not been detected in the skin 
70
. During inflammation, AIM2 inflammasome 
112
 and caspase-1 become activated both in professional immune cells and in 
keratinocytes and induce the abnormal inflammatory responses observed in inflammatory 
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skin diseases. The regulation of caspase-1 is undoubtedly an important checkpoint in IL-
1β production and, thus, in the pathogenesis of chronic inflammatory skin diseases, such 
as psoriasis. By performing a set of in vitro experiments in this study, we have 
demonstrated that CARD18, an endogenous decoy protein proposed to interfere with 
caspase-1 activation, is part of the inflammasome regulatory processes that has been 
previously described 
70,75
. Moreover, our primary expression experiments clearly showed 
that CARD18 exhibits aberrant expression and inductivity in psoriatic epidermis. 
Although knowledge of CARD18 and other COP family members is limited, these small 
proteins could be promising targets for treating inflammatory diseases. Our findings 
regarding misregulated CARD18 expression in psoriasis suggest that this molecule may 
contribute to disease pathogenesis and could be a potential target for therapy.  
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6. SUMMARY 
 
In our work, we have investigated the characteristics and function of two molecules, 
PRINS and CARD18, which may contribute to the stress responses of epithelial cell and 
the initiation of psoriasis. Both molecules have been identified previously by our research 
group as differentially expressed transcripts in healthy and psoriatic epidermis. 
We have earlier described a novel non-coding RNA, PRINS that was overexpressed in 
non-lesional psoriatic epidermis and its expression was induced by various stress factors 
such as serum starvation, contact inhibition, UV-B irradiation, and microbial agents in 
HaCaT cells. In this work we analyzed PRINS expression in thirteen different tissue 
types. In situ hybridization experiments demonstrated variable staining patterns in human 
tissue samples, moreover, we observed tissue specific expression of PRINS in human 
skin: in the epidermis strong PRINS staining was seen in contrast to the dermis, where a 
very slight PRINS expression could be detected. Next, we compared the healthy and 
psoriatic skin: a low PRINS expression elevation was observed in psoriatic involved and 
non-involved epidermis compared to the healthy epidermis. The previous examination of 
our workgroup identified nucleophosmin (NPM) as a PRINS-interacting partner. We 
investigated the subcellular localization changes of NPM protein upon UV-irradiation. 
We demonstrated an induction of NPM shuttling from the nucleolus to the nucleoplasm in 
keratinocytes. To explore whether PRINS ncRNA has any functional role in UV-
mediated cellular stress responses, we silenced the PRINS gene expression in HPV-Ker 
cells and monitored NPM intracellular localization. Silencing of the PRINS non-coding 
RNA expression in the UV-B irradiated keratinocytes resulted in the retention of NPM in 
the nucleolus, suggesting that PRINS is physically and functionally linked to NPM, thus 
plays a role in the NPM-mediated cellular stress response. 
CARD18 is known as a negative regulatory molecule that inhibits inflammatory events 
by terminating inflammasome activation due to a direct interaction with pro-caspase-1. 
During the investigation of molecular mechanisms in keratinocytes that contribute to the 
pathogenesis of psoriasis, we found that CARD18 expression differs in healthy and 
psoriatic skin; moreover, CARD18 demonstrated altered response under inflammatory 
conditions in healthy and psoriatic skin. In healthy skin, low basal CARD18 expression 
was detected, which showed significant elevation in response to inflammatory stimuli 
(lymphokine treatment or mechanical injury). In contrast with this, higher basal 
expression was observed in psoriatic non-involved skin, but no further CARD18 
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induction could be detected. The investigation of cellular inflammatory processes 
revealed that psoriasis-associated danger signals triggered the expression of 
inflammasome components (AIM2, caspase-1) and CARD18 as well as IL-1β production 
of keratinocytes. Furthermore, gene-specific silencing of CARD18 in cells treated with 
cytosolic DNA (poly(dA:dT)) resulted in increased IL-1β secretion, suggesting a negative 
regulatory role for CARD18 in keratinocyte inflammatory signaling. The differential 
regulation of CARD18 in healthy and psoriatic uninvolved epidermis may contribute to 
psoriasis susceptibility. Furthermore, our in vitro results indicate that CARD18 may 
contribute to the fine tuning of keratinocyte innate immune processes. 
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APPENDIX 
 
Supplementary data 
 
Supplementary Fig. 1. The efficacy of PRINS gene-specific silencing.  
PRINS expression was determined by real-time RT-PCR in HPV-Ker cells incubated 
with transfection reagent (control), transfected with scrambled sequence, or transfected 
with PRINS siRNA duplex. Expression is relative to mock-transfected cells. * P>0.05 
 
 
Supplementary Fig. 2. The efficacy of CARD18 gene-specific silencing.  
CARD18 expression was determined by real-time RT-PCR in NHEK cells incubated with 
transfection reagent (mock), transfected with scrambled sequence, or transfected with 
CARD18 siRNA duplex. Expression is relative to mock-transfected cells. * P>0.05 
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Supplementary Fig. 3. Negative-control staining of CARD18 upon acute barrier 
disruption. Skin samples: healthy untreated (A), healthy TS at 24 h (B), healthy TS at 48 
h (C), psoriatic non-involved untreated (D), psoriatic non-involved TS at 24 h (E), 
psoriatic non-involved TS at 48 h (F), psoriatic involved untreated (G), psoriatic involved 
TS at 24 h (H), psoriatic involved TS at 48 h (I). Bar = 100 μm 
 
 
 
Supplementary Fig. 4. The effect of CARD18 gene-specific silencing in NHEKs 
treated with T-cell lymphokine. Following CARD18 silencing, NHEK cultures (n=3) 
were incubated with GM-CSF, IL-3, and IFN-ɣ for 12 hours. AIM2 (A) and caspase-1(B) 
mRNA expression was analyzed by real-time RT-PCR at the indicated time. Expression 
is relative to the 0 hour sample. * P>0.05 
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Abstract: PRINS, a noncoding RNA identified earlier by our research group, contributes 
to psoriasis susceptibility and cellular stress response. We have now studied the cellular 
and histological distribution of PRINS by using in situ hybridization and demonstrated 
variable expressions in different human tissues and a consistent staining pattern in 
epidermal keratinocytes and in vitro cultured keratinocytes. To identify the cellular 
function(s) of PRINS, we searched for a direct interacting partner(s) of this stress-induced 
molecule. In HaCaT and NHEK cell lysates, the protein proved to be nucleophosmin 
(NPM) protein as a potential physical interactor with PRINS. Immunohistochemical 
experiments revealed an elevated expression of NPM in the dividing cells of the basal 
layers of psoriatic involved skin samples as compared with healthy and psoriatic 
uninvolved samples. Others have previously shown that NPM is a ubiquitously expressed 
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nucleolar phosphoprotein which shuttles to the nucleoplasm after UV-B irradiation  
in fibroblasts and cancer cells. We detected a similar translocation of NPM in  
UV-B-irradiated cultured keratinocytes. The gene-specific silencing of PRINS resulted in 
the retention of NPM in the nucleolus of UV-B-irradiated keratinocytes; suggesting that 
PRINS may play a role in the NPM-mediated cellular stress response in the skin. 
Keywords: noncoding RNA; nucleophosmin; keratinocyte proliferation; psoriasis;  
UV-B irradiation 
 
1. Introduction 
Psoriasis is a multifactorial, hyperproliferative, chronic inflammatory skin disease that affects  
1%–3% of the adult Caucasian population (OMIM 177,900, www.ncbi.nlm.nih.gov), with a substantial 
negative impact on the patient’s quality of life [1]. Immunoregulatory abnormalities [2] as well as 
environmental and genetic factors [3,4] contribute jointly to the development of psoriasis. 
Hyperproliferation of the keratinocytes in the psoriatic plaques is triggered by infiltrating  
T-lymphocytes at the dermal–epidermal junction [5]. The keratinocytes of the uninvolved psoriatic 
epidermis are inherently oversensitive to proliferative signals, and this elevated level of sensitivity 
plays a crucial role in the development of psoriatic lesions [6,7]. Thus, resident skin cells and 
infiltrating immune cells cooperate in the formation of psoriatic lesions, but the exact molecular 
mechanisms that regulate the interactions between these cells are still far from understood. The 
identification of genes and proteins with altered expressions, either in the uninvolved or in the 
involved psoriatic skin, may therefore facilitate an understanding of the pathogenesis of this disease. 
While investigations of the molecular mechanisms behind psoriasis have identified numerous  
disease-associated genes and proteins [8–12], it is still unclear how the altered expressions of some 
genes contribute to the pathogenesis of psoriasis, how the differentially expressed molecules exert their 
action and what other molecules they may interact with. 
We demonstrated earlier that PRINS, (psoriasis susceptibility-related RNA gene induced by stress), 
a noncoding RNA (ncRNA) first identified by our research group, is expressed more strongly in the 
uninvolved psoriatic epidermis than in the psoriatic involved or healthy epidermis, suggesting that the 
overexpression of PRINS in the uninvolved psoriatic epidermis may play a role in psoriasis 
susceptibility. Our in vitro experiments also revealed that PRINS functions as a regulatory RNA, 
playing a protective role in cells exposed to stress [13]. 
Since their first detection [14] numerous mRNA-like ncRNA transcripts have been found in 
different cell types. Besides alternative splicing and promoter-driven regulation, ncRNA molecules 
comprise a new level of regulation of protein-coding genes [15]. As yet few papers have provided 
partial or full descriptions of the structural complexes formed by ncRNAs and their protein  
partners [16–18], and their participation and roles in different cellular processes are still poorly 
understood. PRINS an RNA polymerase II transcribed RNA, is a 3681 nucleotide-long molecule. We 
originally described it in HaCaT keratinocytes where it participates in cellular stress response. BLAST 
searches (http://blast.ncbi.nlm.nih.gov/Blast.cgi) revealed that the PRINS gene is specific for 
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anthropoid primates, its rodent ortholog could not be identified [13]. Our studies demonstrated a higher 
PRINS expression in the uninvolved psoriatic epidermis than in either the psoriatic involved or healthy 
epidermis [13]. These results suggest that the overexpression of PRINS in the uninvolved psoriatic 
epidermis may play a role in psoriasis susceptibility rather than in the precipitation of psoriatic lesions, 
and are in agreement with the previous observations that the keratinocytes of the uninvolved epidermis 
differ from healthy keratinocytes in their responses to external stimuli [6,19,20]. We additionally 
showed that PRINS may possess regulatory functions: the expression of the antiapoptotic G1P3 gene 
was found to be under the control of PRINS in various cell types [21]. 
We now report on the cellular and histological distribution of PRINS, determined by using in situ 
hybridization (ISH). Moreover, we present the results of an in vitro binding assay which suggests that 
PRINS interacts physically with the molecular chaperone protein nucleophosmin (NPM, B23) in 
HaCaT and normal human epidermal keratinocyte (NHEK) lysates and describe the first upregulation 
of this protein in psoriasis. 
NPM is a nucleolar phosphoprotein [22] with a potential role as a positive regulator in cell 
proliferation [23,24]. A number of studies have shown that UV irradiation results in a  
rapid nucleoplasmic translocation of the otherwise predominantly nucleolar protein NPM in  
fibroblasts [25,26] and cancer cells [27,28]. 
Our experiments indicate a similar pattern of intracellular localization of NPM after UV-B exposure 
in cultured keratinocytes, and reveal that the gene-specific silencing of PRINS modifies the  
UV-induced intracellular shuttling of NPM suggesting that NPM is a physical and functional interactor 
of PRINS. 
2. Results and Discussion 
2.1. The Histological and Cellular Distribution of PRINS 
By using real-time RT-PCR, we earlier demonstrated differences in PRINS expression in various 
human tissue samples [13]. For a more detailed analysis of PRINS expression we have now applied 
ISH. To investigate the pattern of PRINS expression pattern in different tissue types, we applied 
paraffin-embedded tissue chips containing thirteen sections from different healthy human organs on 
one slide. The samples were exposed to the same conditions during ISH, and this led to good 
comparability. The intracellular distribution of PRINS was also examined in cultured NHEKs. 
The ISH experiments demonstrated variable levels of expression in different human tissue samples: 
high levels of PRINS expression were detected in the gut, lungs, lymph nodes, uterus, testicles and 
skin (Figure 1A–H), whereas no staining was observed in the cerebrum and cerebellum (data not 
shown). The breast, kidney, stomach, and gallbladder tissue specimens displayed only moderate 
PRINS expressions (data not shown). These findings are in agreement with our previous results 
revealing variable PRINS gene expression levels in different healthy human organs. ISH demonstrated 
a relatively high PRINS positivity in the healthy epidermis. 
The dermal and epidermal expression of PRINS significantly differed while a strong staining 
intensity in the epidermis was similar in the various layers. The stratum granulosum and stratum 
lucidum exhibited somewhat darker PRINS ISH staining (Figure 1G,H), which seemed to be specific, 
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since the scrambled control probe did not result in the same staining intensity in these layers. There 
was only a moderate positivity in the dermis. In in vitro cultured keratinocytes (Figure 1I) exhibited 
strong nucleolar (indicated by small arrows) and perinuclear PRINS positivity and moderate 
homogeneous cytoplasmic staining. The cellular expression profile of PRINS is in agreement with the 
epidermal staining pattern. 
Figure 1. Detection of psoriasis susceptibility-related RNA gene induced by stress 
(PRINS) expression in various human tissue samples by ISH. The sections were incubated 
with an LNA RNA detection probe for PRINS and for the control staining (see insets at the 
same magnification) we used a scrambled control sequence. Relatively strong PRINS 
positivity was seen in the (A) lungs; (B) the large bowel; (C) the small bowel;  
(D) the lymph nodes; (E) the uterus; (F) the testicles; (G,H) the skin; and  
(I) cultured keratinocytes. 
 
2.2. PRINS Expression in Healthy and Psoriatic Skin 
ISH experiments were performed to compare the expressions of PRINS in normal healthy (n = 10), 
psoriatic uninvolved (n = 6) and psoriatic involved (n = 6) skin samples. With a quantitative RT-PCR 
approach we earlier showed that PRINS was expressed more strongly in the psoriatic uninvolved 
epidermis than in either the normal or the involved epidermis [13].  
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The ISH results partially confirmed the Q-RT-PCR findings, indicating a moderately elevated level 
of PRINS expression in the uninvolved (Figure 2B) and involved (Figure 2C) epidermis relative to the 
healthy epidermis (Figure 2A). However, the differences in expression between the involved and 
uninvolved epidermis were not as pronounced as with the Q-RT-PCR approach. The explanation for 
this may lie in the different sensitivities of the two methods. 
The differential distribution of PRINS (a multiple stress-related ncRNA) in the epidermal 
keratinocytes could be correlated with the abnormal keratinocyte functions seen in psoriasis and with 
the skin-relevant stress factors inducing the epidermal stress response. 
Figure 2. Detection of PRINS expression in psoriasis. ISH for PRINS expression was 
performed on healthy normal (n = 10), psoriatic uninvolved (n = 6) and psoriatic involved 
(n = 6) skin specimens. Sections were incubated with the PRINS-specific LNA probe or 
with the control scrambled (see insets at the same magnification) LNA probe. 
Representative stainings for each tissue types: (A) normal healthy skin; (B) psoriatic 
uninvolved skin; and (C) psoriatic involved skin. Bar = 100 µm. 
 
2.3. In Vitro Identification of NPM as a PRINS-Interacting Protein 
Our previous data suggested roles for PRINS in psoriasis susceptibility and the cellular stress 
response. It is also accepted that long mRNA-like ncRNAs form complexes with proteins [16–18], and 
act as regulators of various cellular functions [29]. 
To investigate the molecular mechanisms involved in the stress-related functions of PRINS, we first 
searched for its intracellular counterparts. In an in vitro experiment (Figure 3A) we used a 39mer RNA 
transcript of PRINS; this region harbors the 19mer sequence of the gene successfully used for the 
gene-specific silencing of PRINS [13]. For the identification of PRINS-interacting proteins, in vitro 
transcribed RNA (PRINS AK676 sequence) was added to a tobramycin affinity matrix and the cell 
lysates were also added to the column. After several washing steps, the RNP particles were eluted from 
the tobramycin matrix and transferred to a streptavidin affinity matrix. Control elutes were taken from 
both the tobramycin and streptavidin columns, where the cellular extracts were added to the affinity 
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matrix without the bound in vitro transcribed PRINS sequence. The elutes obtained with the  
RNP-complex purification kit were run on SDS-PAGE (Figure 3B). Bands (one with a molecular 
weight of >216 kD and another of ~50 kD) that appeared in the PRINS- binding fraction (S, F3) but not 
for the control samples (Tend, Send) were cut out from the gel and further analyzed with matrix-assisted 
laser desorption/ionization time-of-flight (MALDI-TOF) mass spectrometer. The in vitro binding assay 
was performed and consecutive experiments with three independent cell lysates (two from HaCaT 
keratinocytes and one from NHEKs). 
Figure 3. Identification of the direct interacting partner of PRINS. The in vitro binding 
assay and the consecutive experiments with the three independent cell lysates (two from 
HaCaT keratinocytes and one from cultured NHEK) were performed as depicted in the 
Figure. A 39mer RNA transcript of PRINS was used. The elutes obtained with the  
RNP-complex purification kit were run on SDS-PAGE. Bands (arrows) that appeared in 
the PRINS binding fraction but not for the control samples, were cut out from the gel and 
further analyzed with MALDI-TOF. (A) Flow chart of the in vitro experiments.  
(B) Following the binding assay in HaCaT cells, the proteins in the eluates were separated 
on 7.5% SDS-PAGE and stained with Coomassie Brilliant Blue. NPM from a ~250-kD 
band was identified by MALDI-TOF (shown by black arrows). S, elute from the 1st 
affinity matrix (tobramycin) bound with the in vitro transcribed PRINS and cellular extract. 
F3, elute from the 2nd affinity matrix (streptavidin) incubated with elute “S”.  
TF, flow-through from the tobramycin affinity matrix incubated with the cellular extract.  
SF, flow-through from the streptavidin affinity matrix incubated with the cellular extract. 
Tend, elute from the tobramycin affinity matrix incubated with the cellular extract.  
Send, elute from the streptavidin affinity matrix incubated with the cellular extract 
 
NPM was identified as a putative PRINS-binding protein in all three independent binding 
experiments. NPM, a multifunctional phosphoprotein, is implicated in mRNA processing [30,31] and 
also in the acute response of mammalian cells to environmental stress, when it stimulates DNA repair 
and reduces apoptosis [26]. It has been demonstrated that NPM forms oligomers involving highly 
conserved short loops, the ionic interactions between the monomeric subunits leading to the formation 
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of a thermo-stable, chemically resistant pentamer; it has also been shown that NPM pentamers can 
form decamers in vitro by packing two pentamers on top of each other in a sandwich-like  
structure [32]. This explains why we identified NPM from a 250 kD band by MALDI-TOF and 
suggests a putative structure for the oligomer that is capable of housing long oligonucleotides such as 
long ncRNAs. Similar protein oligomer-RNA complexes have been documented previously such as the 
hexameric or heptameric complexes of Sm proteins that function as RNA chaperones and fulfill a 
number of central tasks in various types of RNA processing [33], and the bacterial Hfq protein that 
forms hexamers and also functions as an RNA chaperone complex [34]. The heterogeneous nuclear 
ribonucleoproteins (hnRNPs) play an active part in post-transcriptional gene regulation, e.g., RNA 
splicing and regulation of the stability and translation of target mRNAs. Most hnRNPs are primarily 
localized in the nucleoplasm, and can shuttle between the nucleus and the cytoplasm [35]. 
2.4. NPM Is Overexpressed in Psoriatic Involved Epidermis 
The psoriasis-associated expression of PRINS has been clearly established by Sonkoly et al. [13]. 
We asked the question of whether NPM gave a characteristic pattern of staining that might  
correlate with the known overexpression of PRINS in the psoriatic uninvolved epidermis. NPM 
immunopositivity was apparent in all the studied skin samples. In both the healthy (Figure 4a) and the 
psoriatic uninvolved (Figure 4c) skin, the keratinocytes presented a nuclear staining throughout all of 
the epidermal layers. Although there were some subgranular nuclei that exhibited a high density of 
brown color in the healthy epidermis, a higher rate of positivity was noted among the spinous 
suprabasal keratinocytes than among the granular and subgranular keratinocytes in the uninvolved 
epidermis (Figure 4c). This finding is in agreement with previously reported ISH results [36] that 
indicated the highest accumulation of NPM transcript in the nuclei of epithelial cells. In the dermis, 
infiltrating immune cells and blood displayed showed pronounced nuclear NPM staining (small 
arrows). The cellular distribution of PRINS and that of NPM in the healthy epidermis showed 
similarities, supporting our results concerning their physical interaction. 
In the psoriatic involved skin, the different layers of the epidermis exhibited different NPM protein 
expression patterns. In the extended spinous layer, only moderate NPM staining was detected, while in 
the basal layer and in the immediate suprabasal layer NPM was expressed at high levels. The most 
interesting phenomenon was seen in the basal layer of the psoriatic involved epidermis (Figure 4e), 
where certain nests of dividing keratinocytes presented marked cytoplasmic immunopositivity besides 
nuclear staining. This staining pattern finally resulted in a very interesting “speckled” overall image in 
the psoriatic involved epidermis. This finding is in accord with the results of Amin and co-workers 
who recently reported that NPM is localized at the chromosome periphery during mitosis [37], when 
the nuclear membrane is demolished. We hypothesize that the interesting “speckled” staining pattern 
of the basal keratinocytes in the involved psoriatic epidermis reflects this phenomenon. 
In a previous study of the expression of NPM, exclusive nuclear staining was seen in squamous cell 
carcinoma, whereas in basal cell carcinoma samples a certain level of cytoplasmic NMP 
immunopositivity was also apparent [38]. These observations suggest that NPM may play a role in 
normal keratinocyte proliferation and its overexpression is a key motive in certain hyperproliferative 
and malignant skin diseases. 
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Figure 4. Immunohistochemical analysis of nucleophosmin (NPM) protein expressions in 
healthy and psoriatic skin samples. Paraffin-embedded tissues of healthy, non-lesional and 
lesional psoriatic skin samples were used for NPM-specific immunohistochemistry. After 
nonspecific antigen blocking, sections were incubated with anti-NPM mouse monoclonal 
antibody at a dilution of 1:500. The incubation with secondary antibody was followed by 
the development of a DAB color reaction, the intensity of which reaction was controlled 
under a light microscope. Sections were counterstained with hematoxylin. In the healthy 
and psoriatic uninvolved skin, the keratinocytes presented nuclear staining throughout all 
of the epidermal layers. In the healthy epidermis, some subgranular nuclei showed a high 
density of NPM, while in the uninvolved epidermis, a higher rate of spinous suprabasal 
nuclear staining was observed. In the psoriatic involved skin, the various layers of the 
epidermis exhibited a different NPM protein expression pattern. The keratinocytes 
presented pronounced cytoplasmic immunopositivity besides nuclear staining.  
Bar = 100 µm; (a) healthy epidermis; (b) isotype control for healthy epidermis;  
(c) psoriatic non-lesional; (d) isotype control for psoriatic non-lesional; (e) psoriatic 
lesional epidermis; (f) isotype control for lesional psoriatic epidermis. 
 
2.5. NPM Expression Decreases as Keratinocytes Differentiate 
Since the epidermal keratinocytes were found to express NPM at high levels, we investigated 
whether this expression was dependent on the proliferation/differentiation state of the keratinocytes. In 
a set of in vitro experiments on spontaneously differentiating 3rd passage NHEKs, the process of 
differentiation was followed via the increase in a differentiation marker (keratin 10) and the decrease 
in a proliferation-related marker (alpha5 integrin) (Figure S1). The 0-h samples were taken from 
subconfluent cultures. Real-time RT-PCR experiments (n = 3) (Figure 5A) and Western blot 
experiments (n = 3) (Figure 5B) revealed that the NPM mRNA and protein expressions were highest 
on days 1 and 2 and then gradually declined during the 10-day follow-up. 
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Figure 5. Expression of NPM protein during keratinocyte proliferation/differentiation  
in vitro. Cultured normal human epidermal keratinocyte (NHEK) cultures (n = 3) were 
grown until subconfluency, when the 0-h sample was taken. (A) Changes in the expression 
of NPM mRNA were analyzed by real-time RT-PCR at the indicated times. Relative 
expression is shown compared to the 0-h sample. (B) At the indicated times, cells were 
harvested and lysed, then subjected to denaturing SDS-PAGE analysis and electroblotted to 
nitrocellulose. NPM protein was detected with a mouse monoclonal anti-NPM antibody 
and visualized with the NBT/BCIP system. 
 
The transcriptional level upregulation of NPM occurred in proliferating cells and, although a slight 
decline in NPM level was observed, the protein remained at a high level in the less proliferating, more 
differentiated keratinocytes when the alpha5 integrin was already decreasing [39], suggesting that the 
NPM protein is relatively stable once expressed in the cells. The fact that the mRNA level decreased 
rapidly (day 4), while the protein level in the keratinocytes declined in a prolonged, more moderate 
manner (day 8), indicates that posttranscriptional, translational regulation and posttranslational 
modifications such as phosphorylation during the maturation and processing of the protein might play 
important roles in the NPM protein expression in keratinocytes. NPM is known to be phosphorylated 
by protein kinase CK2 in the interphase [40] and by p34cdc2 kinase during mitosis [41,42]. It has also 
been shown that the level of NPM phosphorylation correlates with the cellular proliferative  
activity and is enhanced at mitosis [43–46]. However, a precise determination of exactly which 
phosphorylation pathway(s) play(s) a role in NPM stabilization in the keratinocytes requires  
further experiments. 
2.6. Intracellular Localization of NPM Protein in Keratinocytes 
NPM is a ubiquitously expressed nuclear phosphoprotein which shuttles continuously between the 
nucleus and the cytoplasm [47]. Within the nucleus, NPM is predominantly localized in the nucleoli, 
with its highest levels in the granular component that contains the more mature preribosomal  
particles [22], but a significant fraction of NPM can also be detected in the nucleoplasm. NPM is a 
multifunctional protein with multiple locations in the cell. During the cell cycle, NMP is dynamically 
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localized [37] and it is also redistributed from the nucleolus in response to cytotoxic drugs and 
genotoxic stress. In fibroblasts and cancer cells, UV irradiation results in a rapid nucleoplasmic 
translocation of the nucleolar NPM [25,27]. To investigate whether we could observe a similar 
intracellular localization of NPM in keratinocytes after UV-irradiation, we applied an 
immunocytochemistry method. In these experiments, we used a newly established keratinocyte cell 
line, HPV-Ker [48]. The UV responses of NHEKs and HPV-Ker cells were compared. The viability 
and the expression of several UV-induced genes were identical in the two cell types. Moreover, the 
stress-induced p53 gene expression in the HPV-Ker cells presented the same UV-B inducibility as that 
in the NHEKs. The functional similarities between the NHEKs and the HPV-Ker cells suggested that 
HPV-Ker cells are good model cells for the study of UV-induced keratinocyte functions. 
UV-B exposure caused a relocalization of NPM from the nucleolus to the nucleoplasm in HPV-Ker 
cells (Figure 6). The UV-B-induced subcellular shuttling could be detected quite early after UV-B 
irradiation: 3 h after treatment, slight translocational changes were observed. The immunofluorescence 
in the nucleoplasm was most increased at 12 and 24 h. Forty-eight hours following UV-B treatment, 
the protein had mostly returned to the nucleolus. The time course studies showed that the stimulation 
of NPM shuttling by UV-B irradiation was a rapid and transient process. The intracellular localization 
pattern of NPM after UV-B exposure was similar in both the cultured NHEKs (Figure S2) and the 
HPV-Ker cells, which suggests that HPV-Ker cells could be appropriate models for further studies of 
intracellular NPM trafficking. 
Figure 6. UV-B radiation induces the intracellular trafficking of nucleoplasmic NPM in 
HPV-Ker cells. Unirradiated and UV-B-irradiated (312 nm, 40 mJ/cm2) HPV-Ker cells 
were followed for the indicated periods of time, fixed and immunostained for NPM. DNA 
was stained with 4,6-diamidino-2-phenylindole (DAPI). 
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2.7. PRINS Modifies the UV-B Irradiation-Induced Intracellular Shuttling of NPM 
To determine whether PRINS had any effect on NPM intracellular trafficking, we silenced the 
expression of PRINS in growth factor-deprived HPV-Ker cells with a vector-based method [13] and 
studied the NPM shuttling under normal conditions and after UV-B exposure. NPM shuttling was 
compared in HPV-Ker cells transfected with a specific PRINS-silencing construct (AK696) and in 
HPV-Ker cells transfected with a control construct (SC1313). Real-time RT-PCR revealed successful 
gene-specific PRINS silencing (Figure S3A), which resulted in a moderate induction of NPM 
expression (Figure S3B).  
In untreated samples, the NPM was localized mostly within the nucleolus in both the SC1313 and 
the AK696-transfected cells (Figure 7A). The relocalization of NPM from the nucleolus to the 
nucleoplasm in the control SC1313-transfected cells at the indicated times after UV-B exposure was 
similar to our preliminary observations in HPV-Ker cells. As compared with the control cells, the 
AK696-transfected cells (Figure 7B) showed a moderate retention of NPM in the nucleolus following 
UV-B treatment. To validate the immunocytochemical observations, a semiquantitative analysis was 
performed (Figure 7C). The nuclear transition of NPM was inhibited in AK696-transfected cells after 
UV-B irradiation. Interestingly, we observed that the transfection itself slightly modified the shuttling 
of NPM even in the UV-B negative group. 
Figure 7. Silencing of the PRINS expression modifies the UV-B-induced trafficking of 
NPM. HPV-Ker cells were transfected with a PRINS gene-specific silencing vector 
(AK696). Control cells were transfected with a vector containing a scrambled sequence 
(SC1313). One day after the transfection, the unirradiated (A) and the UV-B-irradiated (B) 
HPV-Ker cells were followed for the indicated periods of time, fixed and immunostained 
for NPM (red). DNA was stained with DAPI (blue). Following the immunostaining, we 
performed a semiquantitative analysis of the cells. In every group, 25 fields of view were 
counted. Mean values are plotted on the chart (C). 
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Figure 7. Cont. 
 
Besides the above-described NPM immunocytochemical detection, the shuttling of the protein was 
also studied by using an NPM-GFP chimeric construct. The results of the two experimental approaches 
were identical: both suggested that PRINS contributes to the UV-B-induced intracellular trafficking of 
NPM (Figure S4). 
Our data indicate that PRINS does not act alone, but forms a complex with the NPM protein and 
contributes to its stress-related intracellular trafficking. 
2.8. In Silico Prediction and Gene-Specific Silencing Experiments Suggest that PRINS Might Be Part 
of the Transcription Regulatory CTCF/NPM Complex and Acts as a Negative Regulator of Cell  
Cycle Progression 
It has recently been demonstrated that NPM is a major interacting protein of the zinc finger protein 
CCCTC binding factor (CTCF), which is known to be a critical mediator of multiple epigenetic 
processes [49]. The gene-specific silencing of NPM causes severe mitotic defects and delayed mitotic 
progression, suggesting a crucial regulatory role in cell proliferation [37]. 
Interestingly, when we performed an in silico prediction, transcriptional regulators with 11 highly 
conserved zinc finger domains were among the potential PRINS-binding proteins and the  
NPM-interacting CTCF binding factor belongs in this zinc finger protein family (Table S1).  
CyclinD1, a known target gene of the NPM/CTCF factor regulatory complex, is upregulated in 
psoriasis [50]. In our preliminary experiments, the gene-specific silencing of PRINS resulted in a 
substantial induction of cyclin D1 expression (data not shown). Moreover, we also showed that the 
silencing of PRINS resulted in a slight elevation of NPM expression (Figure S3B). This finding is in 
good agreement with the differentiation-related expression of PRINS: it is expressed most strongly in 
serum-starved, contact-inhibited HaCaT keratinocytes and its expression decreases as the cells start  
to proliferate after release from cell quiescence; moreover, PRINS is strongly expressed in  
the uninvolved psoriatic epidermis and its expression is substantially downregulated in the 
hyperproliferative involved epidermis [13]. These data indicate that PRINS might be part of the 
transcription regulatory CTCF/NPM complex, and as part of this molecular complex it plays a negative 
regulatory role in the cell cycle progression. The involvement of long ncRNAs in molecular regulatory 
complexes has already been documented in the literature [16]. 
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3. Experimental Section  
3.1. Cell Cultures 
HaCaT keratinocytes, the immortalized human keratinocyte cell line kindly provided by  
Dr. Fusenig, N.E. (Heidelberg, Germany), was cultured to subconfluency in T75 tissue culture flasks 
(Corning Incorporated, Corning NY USA) and maintained in keratinocyte serum-free medium (Gibco® 
Keratinocyte SFM Kit; Life Technologies, Copenhagen, Denmark) supplemented with 1% 
antibiotic/antimycotic solution (PAA, Pasching, Austria) and 1% L-glutamine (PAA, Pasching, 
Austria) at 37 °C in a humidified atmosphere containing 5% CO2. The medium was changed every  
two days. Cells were synchronized as described previously [39]. 
NHEKs were obtained from normal human epidermis and cultured as described earlier [51]. 
Briefly, NHEKs were separated from a skin specimen obtained from the Plastic Surgery Unit of our 
Dermatology Department. The epidermis and the dermis were separated by overnight incubation in 
Dispase (Roche Diagnostics, Manheim, Germany), and the keratinocytes were obtained after a 
maceration in 0.25% trypsin. Cells were maintained in keratinocyte serum-free medium (Gibco® 
Keratinocyte SFM Kit; Life Technologies, Copenhagen, Denmark), which contains EGF and BPE as 
supplements. The calcium concentration of the medium is <0.1 mM. For the experiments 3rd passage 
keratinocytes were used. In our in vitro differentiating model, fresh medium was added to subconfluent 
3rd passage keratinocytes and samples were taken from the culture at the indicated time points. The 
rapid upregulation of alpha5 integrin on day 1 indicated intensive keratinocyte proliferation and, as the 
culture became confluent on day 2, the expression of alpha5 integrin gradually decreased (Figure S1). 
The HPV-Ker cell line was immortalized by the HPV E6 oncogene as described previously [48]. 
HPV-Ker cells were grown in 75 cm2 cell culture flasks and maintained in keratinocyte serum-free 
medium (Gibco® Keratinocyte SFM Kit; Life Technologies, Copenhagen, Denmark) supplemented 
with 1% antibiotic/antimycotic solution (PAA, Pasching, Austria) and 1% L-glutamine (PAA, 
Pasching, Austria) at 37 °C in a humidified atmosphere containing 5% CO2. The medium was changed 
every two days. 
Cells were subjected to UV-B irradiation (312 nm, 40 mJ/cm2) in phosphate-buffered saline (PBS; 
153 mM NaCl, 7.67 mM Na2HPO4, 2.67 mM NaH2PO4) at room temperature (RT). Immediately after 
irradiation, the PBS was aspirated off, and culture medium was added to the culture dishes. Cells were 
harvested at the indicated times after UV-B exposure. 
3.2. In Situ Hybridization 
Custom LNA mRNA detection probes for PRINS with the sequence  
5'-3': /5DigN/AAGCTTCTGTCCTCATTAGTCTTC/3Dig_N/ and scrambled control sequence  
5'-3': /5DigN/AAGCCTCCGTTCTTATTAGTCTTC/3Dig_N/ were ordered from Exiqon (Exiqon 
A/S, Vedbaek, Denmark). 
Tissue chips: Formaldehyde-fixed blocks measuring 4 mm in diameter of normal breast, 
cerebellum, cerebrum, gallbladder, kidney, large bowel, small bowel, lung, lymph node, skin, stomach, 
testicle and uterus samples were placed into a tissue microarray (TMA) block. The fixation of samples 
was standardized (4% buffered formaldehyde for 24 h at RT, in a volume of 1:10). After paraffin 
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embedding, the TMA was cut into 4-µm-thick sections, which were rehydrated with increasing 
concentrations of alcohol. 
HPV-Ker cells were trypsinized and harvested by centrifugation, and resuspended in PBS. One 
hundred thousand cells were centrifuged onto a slide by using a cytocentrifuge (Cytopro™, Wescor, 
Logan, UT, USA) and dried overnight at RT. The slides were fixed in 2% paraformaldehyde for  
20 min at RT. 
After 2 × 5-min PBS washes, tissue chip slides and slides with HPV-Ker cells were treated for  
15 min and for 5 min, respectively, with 20 μg/mL proteinase K in PBS at 37 °C. Digoxigenin-labeled 
LNA probes suspended in hybridization buffer (50% formamide) were denatured at 95 °C for 2 min. 
Hybridization was performed at 60 °C overnight. After hybridization, samples were washed in  
5 × SSC (saline–sodium citrate buffer) for 15 min, and then 2 × 30 min in 0.2 × SSC at 60 °C. After a 
10-min PBS wash, samples were equilibrated in 10% goat serum-containing blocking buffer (0.5% 
blocking reagent (Roche, Budapest, Hungary) in PBS containing 0.1% Tween 20) for 1 h at RT and 
then incubated with anti-DIG alkaline phosphatase (AP) conjugate (Roche Diagnostics, Manheim, 
Germany) diluted 1:500 with blocking solution for 1 h. After antibody incubation, samples were 
washed in PBS containing 0.1% Tween-20 for 2 × 10 min and in PBS for 2 × 10 min. Coloring 
reactions were performed overnight with BM purple AP substrate (Roche Diagnostics, Manheim, 
Germany). Slides were mounted with Glycergel (Dako Denmark A/S, Glostrup, Denmark). Pictures 
were taken with the use of a Zeiss AxioImager fluorescent light microscope (Carl Zeiss MicroImaging, 
Thornwood, NY, USA) fitted with a PixeLINK CCD camera (PixeLINK, Ottawa, ON, Canada). 
3.3. In Vitro Binding Assay 
These experiments were conducted in accordance with the instruction manual of the Dual TRAP™ 
RNP Purification KIT (Cytostore Inc., Calgary, AB, Canada). The flow chart of the procedure is 
shown in Figure 2B. RNA template preparation for the binding assay was carried out as follows: 
genomic DNA was isolated from healthy human donor blood with a Perfect gDNA Blood Mini kit 
(Eppendorf, Mannenheim, Germany) in accordance with the manufacturer’s protocol. PCR 
amplification of the template region of the PRINS gene was performed with the following protocol: a 
denaturing step at 94 °C for 5 min, 30 cycles of denaturation at 95 °C for 30 s, annealing at 55 °C for 
30 s, extension at 72 °C for 30 s and one cycle of terminal extension at 72 °C for 2 min. The sequences 
of the EcoRI-AK676 5' FWD (5' GGA ATT CTC CGT CTT AAA GGA AAA AAA TTT CTG 3') and 
Bam-AK715 3' REV (5' CGG GAT CCT AGT CCC TCT CTC TGA TTT ATT G 3') primers used for 
this PCR reaction The PRINS PCR amplicon was cloned into the EcoRI and BamHI site of the 
pPTRAP V5 vector (Cytostore Inc., Calgary, AB, Canada). Transcription was performed on the the 
pTRAP V5 vector linearized with the XhoI restriction enzyme (Sigma Aldrich, St. Louis, MO, USA). 
The efficiency of transcription was tested on 10% PAGE. We used the tagged RNA directly  
(with the reaction mixture) without further purification in the RNA/protein co-incubation and  
purification procedure.  
The in vitro transcribed RNA (PRINS AK676 sequence) was added to the tobramycin affinity 
matrix, and co-incubated with cellular extracts (HaCaT cell extract n = 2; NHEK extract n = 1). The 
washing steps and the elution of the RNP particles were carried out as described in the users’ manual. 
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The eluate (S) was transferred to the streptavidin affinity matrix. A second round of washings and 
elution were carried out (elute F3). Control elutes were obtained from both the tobramycin (Tend) and 
the streptavidin (Send) columns, which did not bind the in vitro transcribed PRINS sequence: the 
cellular extracts flowed through them. In general, we carefully followed the instructions in the manual 
of the RNP purification kit,; however, some modifications were made as follows: during the 
purification of the PRINS RNA/protein complex, when the pre-binding of RNA transcripts to the 1st 
affinity matrix was performed, the in vitro transcribed RNA was incubated with RNAse inhibitor in 
Vial A for 60 min. Co-incubation of the cell extract with the in vitro transcribed RNA on the column 
was carried out overnight and this was followed by a two-step (2 × 30) elution. 
Proteins in the elutes were separated on 7.5% SDS-PAGE and stained with Coomassie Brilliant 
Blue. As marker we, used Kaleidoscope prestained standards (Bio-Rad Laboratories, Cressier, 
Switzerland) containing seven individually color-coded proteins. The bands of interest were cut out 
and identified by MALDI-TOF mass spectrometry. 
3.4. Real-Time RT-PCR 
Total RNA was isolated from cells through the use of TRIzol TM Reagent (Invitrogene Corp., 
Carlsbad, CA, USA), following the manufacturer’s instructions. cDNA was synthesized from  
1 µg total RNA with the iScript cDNA Synthesis Kit (Bio-Rad Laboratories, Hercules, CA, USA). 
Real-time RT-PCR experiments were carried out with the Universal Probe Library system  
(F. Hoffmann-La Roche AG, Basel, Switzerland). The PRINS primers were  
FWD: GAGGCCAGCAGTTTCTACAG and REV: AGGGACAACCACATCAAAGC and  
the Cy5-labeled CCTTCATCTCACACACCTACGCAG probe; NPM primers were FWD: 
GGAGGAGGATGTGAAACTCTTAAG and REV: CTCTTCATCATCATCGTCATCATC and the 
FAM-labeled probe was ATATCTGGAAAGCGGTCTGCCC; each probe was purchased from 
Integrated DNA Technologies Inc., Coralville, IA, USA. PCR assays were performed with an iQ5 
Real-Time PCR Detection Machine (Bio-Rad). The relative mRNA levels were calculated by the ΔΔCt 
method [52]. The expression of each gene was normalized to the 18S ribosomal RNA gene. 
3.5. Western Blot Analysis 
During Western blot analysis, equal amounts of proteins were separated on 10% SDS-PAGE gel, 
transferred to Pure Nitrocellulose Membrane (Bio-Rad Laboratories) and immunoblotted with  
anti-NPM (Sigma Aldrich, St. Louis, MO, USA) antibody diluted 1:500. Anti-mouse IgG alkaline 
phosphate conjugate (Sigma Aldrich, St. Louis, MO, USA) was used as a secondary antibody, and 
signals were visualized with Sigma Fast TM BCIP/NBT (Sigma Aldrich, St. Louis, MO, USA).  
Α-Actin was used as a loading control; α-actin-specific antibody was purchased from Sigma. 
3.6. Immunohistochemistry 
Paraffin-embedded tissues of healthy, involved and uninvolved psoriatic skin samples measuring  
5 mm × 10 mm × 4 mm were obtained for NPM immunohistochemistry. The fixative was 4% buffered 
formaldehyde for 24 h. The tissue block was subjected to paraffin embedding and 4-μm-thick sections 
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were placed on silanized slides, dewaxed in xylene for 3 × 5 min and rehydrated in decreasing 
concentrations of ethanol and methanol for 2 × 3 min and 2 × 2 min, respectively. Tissue endogenous 
peroxidase was blocked in a mixture of 90 mL of methanol and 3 mL of H2O2 for 5 min. For 
nonspecific antigen blocking, a mixture of 1% BSA and 0.1% Azide was used for 10 min. After 
nonspecific antigen blocking, sections were incubated with anti-NPM mouse monoclonal IgG antibody 
(Sigma Aldrich, St. Louis, MO, USA). The antibody was used in a dilution of 1:25 in LabVision 
Solution® (LabVision Corporation, Fremont, CA, USA) overnight. 
For more sensitive reactions, HRP polymer (Envision® system; Dako, Denmark) was applied for  
30 min. The intensity of the DAB reaction (RealEnvision® system; Dako, Denmark) was controlled 
under a light microscope. Sections were counterstained with hematoxylin for 1 min. 
3.7. Gene-Specific Silencing 
Gene-specific silencing of PRINS was performed with a vector-based method described  
previously [13]. The most effective PRINS silencing was achieved in supplement-free HPV-Ker cell 
cultures at ~70% confluency, and the transient transfection with the in vivo pSilencer™ 2.1-U6 hygro 
vector (Ambion Inc., Austin, TX, USA) was therefore carried out with these cells. The siRNA 
sequence targeting PRINS gene silencing was as follows: AK696, TTTCTGGAATGATGTCCAA. 
The scrambled sequence (SC1313) was used as control: AACTTTATCTCGGATCTAT. Cells were 
transiently transfected with plasmids following an X-tremeGENE 9 DNA transfection protocol, as 
described by the manufacturer (Roche Diagnostics, Mannheim, Germany). The transfection efficiency 
was on average 85%, as checked with a GFP reporter construct (Lonza, Basel, Switzerland). The 
effectiveness of the silencing was measured by RT-PCR (Figure S4). 
3.8. Immunocytochemistry 
Control and UV-treated HPV-Ker cells and NHEK cells were trypsinized and harvested by 
centrifugation, and resuspended in PBS. One hundred thousand cells were centrifuged onto a slide 
using a cytocentrifuge (Cytopro™, Wescor, Logan, UT, USA) and dried overnight at RT. The slides 
were fixed in 2% paraformaldehyde for 20 min at RT, and then washed in TBS. Nonspecific antigens 
were blocked for 30 min at RT in 1% goat serum containing 0.5% BSA-TBS. Slides were incubated 
overnight at 4 °C with anti-NPM monoclonal antibody (Sigma Aldrich, St. Louis, MO, USA; 1:500) in 
0.5% BSA-TBS. Anti-mouse Alexa Fluor 546 goat anti-mouse IgG secondary antibody solutions 
(Sigma Aldrich, St. Louis, MO, USA; 1:500) were applied for 3 h at RT. Cell nuclei were 
counterstained with DAPI (Sigma Aldrich, St. Louis, MO, USA, 1:100) and mounted with 
Fluoromont-G (Southern Biotech, Birmingham, AL, USA). Pictures were taken with the aid of a Zeiss 
AxioImager fluorescent light microscope (Carl Zeiss MicroImaging, Thornwood, NY, USA) fitted 
with a PixeLINK CCD camera (PixeLINK, Ottawa, ON, Canada). 
For the semiquantitative analysis of the intracellular localization of NPM (nucleolar or nuclear),  
at least 25 fields of view were counted per each group by two independent examiners. Cells were 
sorted and counted by observing the localization of NPM immunostaining in the nucleolus or in  
the nucleoplasm. 
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3.9. In Silico Prediction of PRINS-Binding Proteins 
In silico prediction of the putative PRINS-binding proteins was carried out with the MatBase 
program (www.genomatix.de). 
4. Conclusions  
We have demonstrated here that the ncRNA PRINS interacts physically and functionally with the 
chaperone molecule NPM. The crucial regulatory roles of NPM in cell proliferation and cellular stress 
response have already been demonstrated [53−55] and studied in detail. In agreement with previous 
findings, we revealed that NPM is associated with proliferation of the keratinocytes. The data we have 
reported here suggest that PRINS might be part of a regulatory complex formed with NPM. The 
resulting complex may play a role in the regulation of proliferation and differentiation and in the stress 
response of cells. We hypothesize that the abnormal functioning of this complex contributes to the 
pathogenesis of both malignant and benign hyperproliferative diseases, such as psoriasis. 
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a  b  s  t  r a  c t
Caspase  recruitment  domain  family  member  18 (CARD18,  Iceberg)  is  known  as  a  negative  regulatory
molecule  that  inhibits  inﬂammatory  events  by  terminating  inﬂammasome  activation  due  to a direct
interaction  with  pro-caspase-1.
During  the  investigation  of molecular  mechanisms  in keratinocytes  that  contribute to  the  pathogenesis
of psoriasis,  we found  that CARD18 expression differs in  healthy  and psoriatic  skin;  moreover,  CARD18
demonstrated  altered  response  under  inﬂammatory  conditions in healthy  and  psoriatic  skin.  In healthy
skin,  low basal  CARD18  expression  was detected, which  showed  signiﬁcant  elevation  in response  to
inﬂammatory  stimuli  (lymphokine  treatment  or  mechanical injury).  In  contrast, higher  basal  expression
was  observed in psoriatic  non-involved  skin, but  no further  induction  could  be  detected.
We  demonstrated  that  keratinocytes  express CARD18 both at  mRNA  and  protein levels and  the  expres-
sion  increased in parallel  with  differentiation. The  investigation  of cellular  inﬂammatory  processes
revealed  that  psoriasis-associated  danger signals  triggered  the  expression of  inﬂammasome  components
(AIM2,  Caspase-1) and  CARD18  as  well  as  IL-1  production of keratinocytes. Furthermore,  gene-speciﬁc
silencing  of CARD18 in cells  treated  with  cytosolic  DNA  (poly(dA:dT)) resulted  in increased IL-1  secre-
tion,  suggesting  a negative regulatory  role for  CARD18  in keratinocyte  inﬂammatory signaling.
The differential regulation  of CARD18  in healthy  and psoriatic uninvolved epidermis may  contribute
to  the  susceptibility  of psoriasis. Furthermore,  our in  vitro  results indicate that  CARD18 may  contribute
to  the  ﬁne tuning of keratinocyte  innate  immune  processes.
©  2016  Published by  Elsevier  Ltd.Abbreviations: AIM2, absence in melanoma 2; CARD18, caspase recruitment
omain family member 18; COP, CARD-only protein; DAPI, 4,6-diamidino-
-phenylindole; DNase, deoxyribonucleases; GM-CSF, granulocyte macrophage
olony-stimulating factor; IL,  interleukin; IFN-γ, interferon-γ; TNF, tumor
ecrosis factor; IHC, immunohistochemistry; NHEK, normal human epidermal
eratinocytes; PBS, phosphate-buffered saline; poly(dA:dT), polydeoxyadenylic
cid–polydeoxythymidylic acid double-stranded homopolymer; TS, tape stripping.
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The innate immune system constitutes the ﬁrst line of  defense
that detects pathogen- and damage-associated molecular patterns.
Inﬂammation is a  protective physiological response; however,
impaired activation and/or down-regulation of inﬂammatory sig-
naling may  result in inﬂammatory diseases, some of which involve
multiple organs. Inﬂammasomes, located in  the cytosol, are part
of the innate immune system. These multi-molecular complexes
are responsible for the recognition of various cytoplasmic dan-
ger signals and provoke inﬂammatory responses by  recruiting and
activating pro-caspase-1 through autocatalytic cleavage (Schroder
and Tschopp, 2010). The activation of caspase-1 ultimately leads to
the processing and, thus, secretion of pro-inﬂammatory cytokines,
most importantly interleukin (IL) 1 and IL-18, and also induces
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yroptotic cell death (Bauernfeind et al., 2011). IL-1 affects nearly
ll cell types and is  fundamental for innate as well as adaptive
mmunity (Dinarello, 1996). Increased IL-1 abundance plays an
mportant role in a number of chronic and acute inﬂammatory
iseases (Li et al., 2008), such as psoriasis.
Psoriasis is  a  life-long skin disease with chronic inﬂammatory
nd immune-mediated characteristics, affecting approximately 2%
f the population (Christophers, 2001). The disease usually man-
fests as raised, erythematous oval plaques on the skin (Nestle
t al., 2009a). In addition to  decreasing the quality of life, psoriasis
s also associated with a  high degree of co-morbidities, includ-
ng arthritis, atherosclerosis, inﬂammatory bowel disease, obesity,
ype 2 diabetes and depression. The clinical phenotype of these co-
orbidities illustrates the importance of the dysfunctional immune
ystem (Rivas Bejarano and Valdecantos, 2013).
The importance of innate immune dysregulation in  psoria-
is has long been recognized (Bos et al., 2005; Nickoloff, 1999;
ickoloff et al., 2000). The activated state of the innate immune sys-
em is  represented by the activity of natural killer cells, dendritic
ells, neutrophils and keratinocytes, and an increased expres-
ion of cytokines (Iversen and Johansen, 2008). Pro-inﬂammatory
ytokines, such as IL-1 and IL-18, have been shown to  play an
mportant role in the pathogenesis of psoriasis, i.e.,  initiating and
ediating the inﬁltration of immune cells and stimulating ker-
tinocytes to proliferate (Johansen et al., 2007; Mee et al., 2007;
estle et al., 2009b). Elevated IL-1 and IL-18 expression has been
bserved in  inﬂamed skin; moreover, the increased IL-1 is  pro-
uced mostly by keratinocytes (Koizumi et al., 2001; Renne et al.,
010). Certain cytokines, inﬂammasomes and inﬂammatory cas-
ases, such as caspase-1, have been described as potential inducers
nd regulators of skin inﬂammation in contact hypersensitivity and
n psoriasis (Iversen and Johansen, 2008; Salskov-Iversen et al.,
011).
Cytosolic DNA is a potent inducer of the innate immune
esponse and has been proposed to be involved in the pathogene-
is of psoriasis (Dombrowski et al., 2011; Lande et al., 2007; Nestle
t al., 2009a). The DNA-sensor-containing absence in melanoma
 (AIM2) inﬂammasome is  triggered by both self-derived and
athogen-released (Francisella tularensis,  Listeria monocytogenes,
accinia virus) cytosolic double-stranded DNA (Fernandes-Alnemri
t al., 2009; Rathinam and Fitzgerald, 2010). Recently, abundant
ytosolic DNA and increased AIM2 expression were found to be
resent in  keratinocytes in  psoriatic lesions but not in  healthy skin
Dombrowski et al., 2011), and have been suggested to contribute
o the abnormal IL-1 secretion in  psoriasis. Keratinocytes express
our different deoxyribonucleases (DNases), which remove extra-
ellular DNA by  degradation. In psoriatic skin, three of these DNases
o not exhibit DNase activity and one seems to have reduced DNA-
fﬁnity. The optimum pH of these DNA-binding proteins likely
hanges during keratinization (Reimer et al., 1978), resulting in
berrant DNase activity and the presence of excess DNA fragments
n the cytosol.
Our recent large-scale gene expression study has revealed that
he caspase recruitment domain family member 18 (CARD18,
ceberg) transcript is  differentially expressed in psoriatic non-
nvolved epidermis compared to healthy epidermis (Szabó et al.,
014). CARD18, a  member of CARD-only protein (COP) family, has
nly one CARD domain which exhibits sequence similarity to  the
ARD prodomain of caspase-1. COP family members probably arose
hrough gene duplication and are restricted to  the higher primates
Kersse et al., 2007). CARD18 serves as a  decoy protein which can
odify the activity of inﬂammasome by inhibiting the generation ofctive IL-1 and IL-18 through direct interaction with pro-caspase-
 (Druilhe et al., 2001; Humke et al., 2000). Further investigation
f the molecular biology and functions of CARD18 should shed
ight on yet unknown basic innate immune mechanisms and couldunology 73 (2016) 10–18 11
lead to  the identiﬁcation of possible therapeutic target(s). There-
fore, we investigated CARD18 expression in  cultured keratinocytes
exposed to various psoriasis-related stress factors and sentinels in
psoriasis. We also addressed whether CARD18 contributes to AIM2
inﬂammasome-mediated keratinocyte functions, and if this small
molecule could modify inﬂammatory processes in  keratinocytes.
2. Materials and methods
2.1. Patients
Shave biopsy samples for organotypic skin cultures were taken
from the non-involved buttock area of ﬁve young male psoriasis
patients and ﬁve age- and gender-matched healthy controls. Sub-
sequently, organotypic skin cultures were established, as has been
described previously (Szabó et al., 2014).
For immunohistochemical staining, patients with moderate-to-
severe psoriasis vulgaris (n =  2) and healthy (n  = 2) volunteers were
enrolled in the study.
In another set of experiments, the skin of psoriatic patients
(n = 2) and healthy volunteers (n = 2) were subjected to  tape strip-
ping (TS). Punch biopsies were taken from the area once before and
twice after (24 and 48 h)  the treatment.
Written informed consent was obtained from all donors
involved in the study. Psoriatic patients had not undergone treat-
ment for 4 weeks before sampling. The study was approved by
the Human Investigation Review Board of the University of Szeged,
complying with the ethical standards of research and in accordance
with the Helsinki Declaration.
2.2. Cell cultures
Normal human epidermal keratinocytes (NHEKs) were sep-
arated from skin specimens obtained from the Plastic Surgery
Unit of our department. The epidermis and the dermis were sep-
arated by overnight incubation in  Dispase (Roche Diagnostics,
Manheim, Germany), and keratinocytes were obtained after macer-
ation in 0.25% trypsin. Cells were grown in  75 cm2 cell culture ﬂasks
and were maintained in keratinocyte serum-free medium (Gibco
Keratinocyte SFM Kit; Life Technologies, Copenhagen, Denmark),
supplemented with 1% antibiotic/antimycotic solution (PAA Lab-
oratories GmBH, Pasching, Austria) and 1% l-glutamine (PAA
Laboratories) at 37 ◦C in a  humidiﬁed atmosphere with 5% CO2.  The
calcium concentration of the medium was  <0.1 mM.  The medium
was changed every 2 days. Third passage keratinocytes were used
for experiments.
A previously described, an in vitro keratinocyte-differentiating
model was used (Pivarcsi et al., 2001). For the induction of AIM2
inﬂammasome, cells were subjected to  5 ng/ml tumor necrosis fac-
tor (TNF)  (R&D Systems, Minneapolis, MN,  USA) and 5  ng/ml
interferon (IFN) γ (R&D Systems) pretreatment and 1 g/ml poly-
deoxyadenylic acid–polydeoxythymidylic acid double-stranded
homopolymer (poly(dA:dT)), (Sigma Aldrich, Saint Louis, MO,  USA)
transfection. The supernatants were collected and cells were har-
vested at the indicated time points after treatments.
2.3. Real-time RT-PCR
Total RNA was  isolated from cells using TRIzol® Reagent (Invit-
rogen Corp., Carlsbad, CA, USA), following the manufacturer’s
instructions. cDNA was synthesized from 1 g total RNA with
the iScript cDNA Synthesis Kit  (Bio-Rad Laboratories, Hercules,
CA, USA). Real-time RT-PCR experiments were carried out with
the Universal Probe Library system (F. Hoffmann-La Roche AG,
Basel, Switzerland). The following primers were used: CARD18
1 r Immunology 73 (2016) 10–18
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Fig. 1. CARD18 gene expression in healthy and non-involved psoriatic epidermis.
Total RNA was isolated from the epidermal compartment of organotypic skin cul-2 A.  Göblös et al. / Molecula
orward AAGACCCCTCAACTTGCCTCA and reverse CTCCCTTGGAA-
AAGCTCTG, (UPL probe number 50); AIM2 forward AGTCCTCT-
CTAGTTAAGCTCTCTG and reverse TCTGACAACTTTGGGATCAGC
UPL probe number 87); and caspase-1 forward CCTTAATATG-
AAGACTCTCAAGGA and reverse TAGCTGGGTTGTCCTGCACT (UPL
robe number 17). PCR assays were performed with the C1000
ouch Thermal Cycler (Bio-Rad Laboratories). The expression of
ach gene was normalized to the 18S ribosomal RNA gene. Rela-
ive mRNA levels were calculated by  the Ct method. Data from
ifferent treatments were compared using one-tailed t-test. Differ-
nces were considered signiﬁcant when P ≤ 0.05.
.4. Immunohistochemistry
Parafﬁn-embedded specimens from healthy, involved and
on-involved psoriatic skin were obtained for CARD18 immunohis-
ochemistry (IHC). Samples were ﬁxed in  4% buffered formaldehyde
or 24 h. The tissue block was subjected to parafﬁn embedding
nd 4-m-thick sections were placed on silanized slides, dewaxed
n xylene for 3 × 5 min  and rehydrated in decreasing concentra-
ions of ethanol. Tissue retrieval was performed in citrate buffer
10 mM,  pH 6.0). For nonspeciﬁc antigen blocking, 1% horse serum
ontaining 0.5% BSA-TBS was used for 30 min. Sections were incu-
ated with anti-CARD18 goat polyclonal IgG antibody (Santa Cruz
iotechnology, Dallas, TX, USA; 1:300) at 4 ◦C overnight. The anti-
ARD18 goat polyclonal antibody was not included in the staining
rocedure when sections were stained for the matching negative
ontrols. After three washing steps with phosphate-buffered saline
PBS), biotinylated anti-goat IgG (1:200, Vector Laboratories Inc.,
urlingame, CA, USA) was  applied for 30 min  at room tempera-
ure. After one PBS wash, sections were incubated in  ExtrAvidin
eroxidase (1:400, Sigma Aldrich) for 30 min  at room tempera-
ure. Visualization was performed by  adding AEC reagent (0.05%
-amino-9-ethylcarbazole dissolved in  N,N-dimethylformamide,
.01% H2O2,  and 0.05 M acetate buffer). Sections were counter-
tained with hematoxylin for 10 s and subsequently analyzed
ith a Zeiss Axio Imager ﬂuorescent light microscope (Carl Zeiss
icroImaging, Thornwood, NY, USA) ﬁtted with a Carl Zeiss Axio-
amMRc camera.
.5. Immunoﬂuorescence staining
NHEK cells were trypsinized, harvested by centrifugation and
esuspended in PBS before 105 cells were centrifuged onto a slide
sing a cytocentrifuge (CytoproTM, Wescor, Logan, UT, USA) and
ried overnight at room temperature. The slides were ﬁxed in
% paraformaldehyde for 20 min  at room temperature. Nonspe-
iﬁc antigens were blocked for 30 min  at room temperature in
% donkey serum containing 0.5% BSA-TBS. Slides were incubated
vernight at 4 ◦C with anti-CARD18 goat polyclonal IgG antibody
Santa Cruz Biotechnology; 1:250) in  0.5% BSA-TBS. Anti-goat Alexa
luor 546 donkey secondary antibody solutions (Sigma Aldrich)
ere applied for 1 h at room temperature. Cell nuclei were counter-
tained with 4,6-diamidino-2-phenylindole (DAPI, Sigma Aldrich,
:100) and mounted with Fluoromount-G (Southern Biotech, Birm-
ngham, AL, USA). Pictures were taken with the aid of a  Zeiss Axio
mager ﬂuorescent light microscope (Carl Zeiss MicroImaging) ﬁt-
ed with a Carl Zeiss AxioCamMRc 5 camera.
.6. ELISACell supernatants were centrifuged (5000 rpm, 4 min, 4 ◦C)  to
ellet cell debris and the amount of IL-1 was determined by
LISA (Human IL-1 ELISA Duo Set, R&D Systems), according to the
anufacturer’s instructions.tures  (n  =  5). CARD18 gene expression patterns in response to  T-cell lymphokine
(GM-CSF, IL-3, IFN-γ) treatment in healthy epidermis and in non-involved psoriatic
epidermis. Horizontal lines represent mean values.* P >  0.05.
2.7. Gene speciﬁc silencing
Gene-speciﬁc silencing was performed with an siRNA trans-
fection method. NHEK cells were transiently transfected at
approximately 70% conﬂuency using the X-tremeGENE siRNA
Transfection Reagent (Roche), according to  the manufacturer’s
instructions. For gene-speciﬁc silencing of CARD18, siRNA duplex
was applied: ICEBERG siRNA (h), sc-105550, and control siRNA-A,
sc-37007 (Santa Cruz Biotechnology). The most effective CARD18
silencing was achieved in serum-free culture medium without
additive and supplements. The effectiveness of the silencing was
measured by real-time RT-PCR (Supplementary Fig. 1).
3. Results
3.1. CARD18 gene expression differs in healthy and psoriatic
non-involved epidermis upon T-cell lymphokine treatment
There is  evidence that psoriatic non-involved epidermal ker-
atinocytes carry molecular and cellular alterations that contribute
to  the occurrence of psoriatic symptoms. We  have recently reported
the results of a cDNA microarray experiments in which 61 anno-
tated genes were differentially expressed in psoriatic non-involved
and healthy epidermis upon T-cell lymphokine treatment (Szabó
et al., 2014). In this experiment, organotypic skin cultures were
treated with a  cytokine mixture (GM-CSF, IL-3, IFN-γ) that has
been shown to mimic  the effect of psoriatic T-cell lymphokines
(Bata-Csorgo et al., 1995). CARD18, identiﬁed as a  differentially
expressed gene in our experiment, encodes a  protein that belongs
to the COP family. CARD18 is a negative regulator of IL-1 matu-
ration, inhibiting inﬂammasome activation directly by interacting
with pro-caspase-1 (Bauernfeind et al., 2011). To validate the cDNA
microarray results, real-time RT-PCR analysis was carried out to
measure the abundance of CARD18 mRNA (Fig. 1) using origi-
nal RNA samples derived from organotypic skin cultures (healthy
epidermis, n =  5,  and psoriatic non-involved epidermis, n =  5). Our
results conﬁrmed the cDNA microarray results: we observed a  2-
fold elevation of CARD18 mRNA level in  psoriatic non-involved
epidermis compared to healthy epidermis. Although the basal
expression levels were relatively high in the psoriatic non-involved
A. Göblös et al. / Molecular Immunology 73 (2016) 10–18 13
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tig. 2. Immunohistochemical staining of CARD18 in healthy and psoriatic skin. CAR
nvolved (C) skin. Negative controls were performed for healthy (D), psoriatic non-i
pidermis, it was not further induced in response to T-cell lym-
hokines. This was in  contrast to the ﬁndings for healthy skin,
here lower basal expression levels were induced with an average
.65-fold elevation in response to the same treatment.
.2. CARD18 expression differs in healthy and diseased skin
Using an organotypic skin model, we  determined that CARD18
RNA abundance was higher in  psoriatic non-involved epidermis
ompared to  healthy epidermis. To compare CARD18 protein levels
n healthy and diseased skin, immunohistochemical (IHC) stain-
ng was performed on parafﬁn-embedded samples from healthy
Fig. 2A), psoriatic non-involved (Fig. 2B) and psoriatic involved
kin samples (Fig. 2C) in  an independent experiment. In all exam-
ned sections, CARD18 appeared exclusively in  the epidermis,
peciﬁcally in the cytoplasm of the epidermal keratinocytes. IHC
evealed differential CARD18 expression in different skin samples:
levated levels were observed in  the psoriatic-involved and non-
nvolved epidermis compared to  the healthy epidermis (Fig. 2B and
C vs 2A). These results conﬁrmed our real-time RT-PCR ﬁndings.
o differences were detected in the different keratinocyte layers of
he epidermis; however, the level of CARD18 staining was  some-
hat higher in the suprabasal layers of psoriatic non-involved and
nvolved epidermis. Fig. 2D–F provides the data from negative con-
rols for Fig. 2A–C.
.3. CARD18 expression is differentially induced in healthy,
soriatic non-involved and psoriatic involved epidermis after tape
tripping (TS)
Mechanical stress causing disruption of the skin barrier leads
o molecular responses, including a rapid increase in DNArotein levels were analyzed in healthy (A), psoriatic non-involved (B), and psoriatic
ed (E) and psoriatic involved skin (F). Bar =  100  m.
synthesis and early over-expression of pro-inﬂammatory cytokines
(Marionnet et al., 2003; Wood et al., 1997). It has long been known
that baseline proliferative activity of keratinocytes of non-involved
skin of psoriatic patients does not differ from keratinocytes in  skin
of healthy individuals; however, the proliferative response to TS
or other trauma is signiﬁcantly higher in psoriatic non-involved
skin compared to healthy skin (Hatta et al., 1997; van de Kerkhof
et al., 1983; Wiley and Weinstein, 1979). CARD18 protein expres-
sion was  observed in mechanically stimulated skin from healthy
and non-involved skin of psoriatic donors. Punch biopsies were
taken before the procedure and two  times after TS (24 and 48  h).
Compared to untreated sections (Fig. 3A, D, G), CARD18 protein
expression level was induced 24 h after TS in healthy (Fig. 3B), psori-
atic non-involved (Fig.  3E) and psoriatic involved (Fig. 3H) samples,
as well. However, the elevation of CARD18 expression in  treated
and untreated psoriatic non-involved samples was not as robust
as in healthy or psoriatic involved skin. Forty-eight hours after the
treatment, CARD18 expression remained elevated only in the psori-
atic non-involved samples (Fig. 3F). Negative-control staining of the
TS experiment is provided in Supplementary data (Supplementary
Fig. 2).
3.4. CARD18 is abundantly expressed in differentiating
keratinocytes
To examine the characteristics of CARD18 in  NHEKs, which are
non-professional immune cells, we examined mRNA and protein
changes in spontaneously differentiating NHEKs. In spontaneously
differentiating third-passage NHEKs, the differentiation process
was detected as an increase in  a differentiation marker, keratin
10, and the decrease in a proliferation-related marker, alpha5
integrin (data not shown). The 0-day samples were taken from
14 A.  Göblös et al. / Molecular Immunology 73 (2016) 10–18
Fig. 3. CARD18 expression upon acute barrier disruption. Tape stripping (TS) method was carried out on  the skin of healthy (n = 2,  one representative picture is  shown) and
psoriatic  volunteers (n =  2,  one representative picture is shown). Punch biopsies were taken at  the indicated time points. Skin samples were subjected to immunohistochemical
staining of CARD18: healthy untreated (A), healthy TS  at 24 h (B), healthy TS  at 48 h (C), psoriatic non-involved untreated (D), psoriatic non-involved TS at 24 h (E), psoriatic
non-involved TS at 48 h  (F), psoriatic involved untreated (G), psoriatic involved TS  at 24 h  (H), psoriatic involved TS  at 48 h  (I). Bar =  100 m.
Fig. 4. Expression of CARD18 mRNA and protein during keratinocyte proliferation and differentiation. Cultured NHEKs (n  =  3) were grown to subconﬂuency before samples
were  taken (0 day). (A) Changes in CARD18 mRNA expression were analyzed by real-time RT-PCR at the indicated time points. Relative expression is  shown compared to the
0-day  sample. (B) CARD18 intracellular protein localization was  detected in NHEKs (n  =  3, one representative picture is shown) at the indicated time points. Samples were
ﬁxed  and immunostained for CARD18 (red). DAPI was  used for nuclear counterstaining. Magniﬁcation: 20×.
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nig. 5.  The response of cytokine-primed keratinocytes to  synthetic DNA analogue (p
4  h, followed by  poly(dA:dT) transfection. Samples were taken at the indicated tim
nd  AIM2 (D) mRNA expression was determined by  real-time RT-PCR. Relative exp
ubconﬂuent cultures. To determine the mRNA expression of
ARD18, real-time RT-PCR was carried out using gene-speciﬁc
rimers. The in vitro gene-expression study revealed low-level
ARD18 mRNA expression in the proliferative state of cells, and
his expression continuously increased during differentiation: up
o 43.2-fold elevation in the 10-day samples (Fig. 4A).
To examine the expression of CARD18 protein, immunoﬂu-
rescence staining was applied to  keratinocytes, revealing that
oderate positive CARD18 protein expression in  samples taken on
ays 0–4 gradually increased in the 6–10-day samples (Fig. 4B).
hus, CARD18 protein expression followed a similar pattern
bserved for the mRNA expression during the 10-day course. The
mmunocytochemistry staining allowed the intracellular distribu-
ion to be determined and revealed that CARD18 was  located in
he cytoplasm of NHEKs, as it was observed in  the epidermal ker-
tinocytes of the ex vivo samples.
.5. CARD18 modiﬁes the expression of molecules involved in
ytosolic DNA-triggered responses of NHEKs
To elucidate the cellular processes in which CARD18 participates
nd to gain further insight into its role in  the pathome-
hanism of psoriasis, we investigated CARD18 expression in
esponse to certain psoriasis-associated signals. Keratinocytes, as
mportant immune-competent cells, are able to sense danger sig-
als and mediate immune response through the activation ofA:dT)) transfection. NHEK cultures (n = 3) were incubated with IFN-γ and TNF-  for
nts. IL-1 secretion (A) was  measured by ELISA method. CARD18 (B),  caspase-1 (C)
ns are shown compared to  the 0  h sample. * P > 0.05.
pro-inﬂammatory signaling pathways (Nestle et al., 2009b), result-
ing in the expression of inﬂammasome components and secretion
of pro-inﬂammatory cytokines (Feldmeyer et al., 2007).
Cytosolic DNA has been identiﬁed recently as a  trigger for AIM2
inﬂammasome activation and is  abundant in psoriatic-involved
epidermis (Chiliveru et al., 2014; Dombrowski et al., 2011). To
mimic  the effect of cytosolic DNA, a synthetic dsDNA analogue
poly(dA:dT) was  transfected into cultured keratinocytes. A signif-
icant increase in IL-1 release – up to 50 pg/ml (Supplementary
Fig. 3A) – as well as 3–5 fold increase in caspase-1 expression
(Supplementary Fig. 3C) and a 200-fold increase in AIM2 expres-
sion (Supplementary Fig. 3D) were observed, although changes in
CARD18 mRNA were not  detected (Supplementary Fig. 3B).
To provoke enhanced inﬂammation, IFN- and TNF- pre-
treatment was performed before poly(dA:dT) transfection. IFN- is
known to induce AIM2 gene expression (Lee et al., 2012), whereas
TNF- mediates pro-IL-1 transcription (Mills and Dunne, 2009),
and both cytokines are consistently elevated in  psoriatic skin.
The co-treatment with IFN-,  TNF- and poly(dA:dT) resulted in
increased IL-1 secretion – up  to  100 pg/ml (Fig. 5A) – and increased
the expression of caspase-1 and AIM2 mRNAs by 13-fold (Fig. 5C)
and 250-fold (Fig. 5D), respectively. CARD18 mRNA level was also
increased by six fold (Fig. 5B).
These results encouraged us to  further characterize the func-
tion of CARD18 in keratinocytes in which inﬂammatory processes
had been induced. CARD18 expression was  silenced by  siRNA
16 A.  Göblös et al. / Molecular Immunology 73 (2016) 10–18
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Fig. 6. The effect of CARD18 gene-speciﬁc silencing in cytokine-primed poly(dA:dT) transfected NHEKs. CARD18 expression was silenced in NHEK cultures (n = 3). CARD18
siRNA,  scrambled control and mock-transfected cells were subsequently treated with a mixture of IFN-γ and TNF- (12 h) and transfected with poly(dA:dT). Samples were
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gaken  at the indicated times. IL-1 secretion (A) was  measured by  ELISA. CARD18
xpression is relative to  the 0 h  sample, except for AIM2, where arbitrary units wer
4 h before IFN- and TNF- treatment and the subsequent
oly(dA:dT) transfection. The applied siRNA effectively down-
egulated CARD18 expression to  50% of the levels observed for the
crambled control cells (Fig. 6B).
The CARD18 silencing resulted in  a  signiﬁcant decrease in AIM2
ene expression 12 and 24 h after treatment (Fig. 6C)  and signiﬁ-
antly reduced caspase-1 mRNA expression (Fig. 6D) 24 h after the
reatment. For further conﬁrmation, we determined whether the
ilencing of CARD18 had any effect on IL-1 secretion: our results
ndicated that downregulation of CARD18 expression affected an
levation of IL-1 production in keratinocytes (Fig. 6A). These
esults indicate that CARD18 might indeed contribute to  the ﬁne-
uning of inﬂammatory processes in keratinocytes and suggest that
 similar to  the role in professional immune cells (Humke et al.,
000) –  functions as a  negative regulator of inﬂammasome activa-
ion in keratinocytes.
. Discussion
IL-1 is  an important mediator in  the in the induction and main-
enance of psoriasis (Bernard et al., 2012; Feldmeyer et al., 2010)
nd represents a  potential therapeutic target; therefore, several
tudies have targeted possible inhibitors of IL-1 (Mansouri et al.,
015; Tamilselvi et al., 2013; Yun et al., 2015). IL-1 and IL-18 are
enerated by  a number of different inﬂammasomes in responseaspase-1 (C) and AIM2 (D)  mRNA expression was analyzed by real-time RT-PCR.
. * P > 0.05.
to  various environmental inﬂuences and this process is  likely fur-
ther modulated by additional genetic factors (Masters, 2013). The
importance of these multi-protein platforms has been reported in
several inﬂammatory diseases, including psoriasis (Dombrowski
et al., 2011; Mason et al., 2011). Speciﬁc inﬂammasome inhibitors
rectify the balance between beneﬁcial and deleterious IL-1 and
IL-18 production. CARD18 has been identiﬁed as a negative regu-
lator of inﬂammasome activation through direct interaction with
the CARD domain of pro-caspase-1 and abrogation of IL-1 and
Il-18 production in  macrophages (Humke et al., 2000). We  have
identiﬁed CARD18 as a highly expressed transcript in  psoriatic non-
involved epidermis and demonstrated its abnormal regulation in
psoriatic non-involved epidermis (Szabó et al., 2014). To under-
stand the pathologic functions of CARD18 in  skin inﬂammation, we
studied CARD18 under normal and inﬂammatory conditions both
in vitro and in vivo.
In  organotypic skin cultures, CARD18 mRNA basal expres-
sion level was  higher in  psoriatic non-involved epidermis than
healthy epidermis. In addition, samples of different origin exhib-
ited different responses to lymphokine induction. The higher basal
expression of CARD18 mRNA in  psoriatic non-involved samples
was not further increased following T-cell lymphokine treatment.
In contrast, healthy epidermis exhibited lower CARD18 mRNA basal
expression, which was induced by the cytokine treatment.
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In human skin, CARD18 protein and mRNA exhibited simi-
ar accumulation patterns: histological staining showed higher
ARD18 expression in  non-involved and involved epidermis than
n healthy epidermis. Mild injury (i.e.,  TS) induced CARD18 pro-
ein expression in all examined skin samples. However, the level
f induction was different: modest elevation was detected in pso-
iatic non-involved epidermis compared to healthy and psoriatic
nvolved epidermis. The higher basal level and the lack of response
f CARD18 gene and protein expression in psoriatic non-involved
pidermis might indicate a  “ceiling effect” or impaired regulation
f inﬂammatory signaling, similar to the phenomenon that has
een described for IL-1 production in keratinocytes and in salivary
lands (Mastrolonardo et al., 2007; Szabó et al., 2014).
Although keratinocytes are able to express inﬂammasome com-
onents and secrete IL-1,  we  observed very low – sometimes
ndetectable – levels of AIM2, caspase-1 and CARD18 mRNA
nd IL-1 secretion in  uninduced keratinocytes. Compared to
he untreated cells, however, treatment with a combination of
nﬂammation-related stress factors signiﬁcantly increased both  the
xpression of inﬂammasome components and IL-1 secretion. The
pplied triggering factors, such as IFN- and TNF- priming fol-
owed by poly(dA:dT) transfection are also known to  contribute to
he pathogenesis of psoriasis (Dombrowski et al., 2011; Nestle et al.,
009a).
To gain some information about the function of CARD18 in ker-
tinocytes under inﬂammatory conditions, we  silenced CARD18
xpression. CARD18 silencing resulted in  a  modest but signiﬁcant
levation of IL-1 secretion in  poly(dA:dT)-treated cells, suggest-
ng that, similar to professional immune cells, CARD18 indeed has a
egative regulatory role in keratinocyte innate immune functions.
nterestingly, reduced inﬂammasome activation was  detected as
ecreased AIM2 and caspase-1 gene expression in the CARD18
ilenced cells. We  hypothesize that IL-1 secretion is  a  highly
egulated process both in professional and in non-professional
mmune cells, such as keratinocytes. Thus, the silencing of CARD18
ight up-  and down-regulate multiple process simultaneously,
esulting in only a mild change in  IL-1 secretion. The reduced
nﬂammasome activation data suggest the present of a negative
eedback loop: elevated active caspase-1 down-regulates caspase-1
nd AIM2 gene expression through a  yet unknown control mech-
nism. Juruj et al. have recently published results supporting this
ypothesis: the authors demonstrated that caspase-1 negatively
egulated the formation or stability of the AIM2 inﬂammasome
omplex, and that this regulation was speciﬁc to the AIM2 inﬂam-
asome pathway in macrophages (Juruj et al., 2013).
Nair and coworkers demonstrated that caspase-1, AIM2 and IL-
 mRNAs are present at low levels in  healthy and non-involved
kin, and that the expression of these molecules increases sig-
iﬁcantly in  psoriatic involved skin (Nair et al., 2009). Moreover,
aspase-1 protein expression is increased in involved psoriatic
kin compared to non-involved psoriatic skin, whereas procaspase-
 expression is  unchanged. Under normal conditions, caspase-1
ctivity has not been detected in the skin (Johansen et al., 2007).
uring inﬂammation, AIM2 inﬂammasome (De Koning et al., 2012)
nd caspase-1 become activated both in professional immune
ells and keratinocytes and induce the abnormal inﬂammatory
esponses observed in  inﬂammatory skin diseases. The regulation
f caspase-1 is undoubtedly an important checkpoint in IL-1 pro-
uction and, thus, in  the pathogenesis of chronic inﬂammatory
kin diseases, such as psoriasis. By performing a  set of in vitro
xperiments in this study, we  have demonstrated that CARD18,
n endogenous decoy protein proposed to interfere with caspase-1
ctivation, is part of the inﬂammasome regulatory processes that
as been previously described (Dombrowski et al., 2011; Johansen
t al., 2007). Moreover, our  primary expression experiments
learly showed that CARD18 exhibits aberrant expression andunology 73 (2016) 10–18 17
inductivity in  psoriatic epidermis. Although knowledge of  CARD18
and other COP family members is limited, these small proteins
could be promising targets for treating inﬂammatory diseases. Our
ﬁndings regarding misregulated CARD18 expression in  psoriasis
suggest that this molecule may  contribute to disease pathogenesis
and could be a potential target for therapy.
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